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Chapter 1  Introduction
Atherosclerosis – a disease of arteries
The cardiovascular system
The human body is equipped with a vascular network consisting of arteries and 
veins. This vascular network effectively supplies all parts of the body with blood 
rich in oxygen and nutrients. The heart, or cardiac muscle, which embodies the 
center of this so-called cardiovascular system, pumps the blood through the 
vasculature by a rhythm of subsequent contractions and relaxations. Oxy-
gen-rich blood is circulated from the lungs, via the heart and arteries, to all 
parts of the body, while a network of veins delivers the resulting oxygen-poor 
blood from all parts of the body back to the heart and subsequently to the 
pulmonary arteries, for re-oxygenation by the lungs. Besides oxygen, other sub-
stances, such as nutrients and waste, are circulated between different organs 
or body parts by the cardiovascular system.
Arteries are tubular structures of varying size, that by definition carry blood 
from the heart to the organs and periphery of the body. The arterial wall is 
made up of three layers: the innermost layer is called the tunica intima, the 
middle layer the tunica media and the outer layer the tunica adventitia. In 
healthy arteries, the intimal layer consists of one layer of endothelial cells on 
a basal lamina and a thin layer of extracellular matrix. The intimal layer covers 
the luminal surface and is separated from the medial layer by an elastic mem-
brane, the internal elastic lamina. The medial layer is composed of several lay-
ers of smooth muscle cells separated by an elastic lamina that, by contracting 
or relaxing, can actively influence the size of the artery. The adventitial layer 
consists of connective tissue, mostly collagen, and provides rigidity. Depending 
on the location of the artery, the medial and adventitial layers vary in thickness. 
Larger arteries, such as the aorta and the carotid arteries, which are located in 
the vicinity of the heart, have a thick medial muscular layer, which is necessary 
to withstand the fluctuations in blood pressure elicited by the pumping heart. 
These arteries are called elastic arteries. Towards the periphery, as the elastic 
arteries pass into muscular arteries and subsequently into arterioles, both the 
diameter and the media thickness of arteries gradually decrease. From the 
arterioles, blood is transported into the capillary beds, a dense network of very 
small vessels. The small vessel size and large surface area of the capillaries al-
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lows for efficient exchange of oxygen and nutrients from the blood to the tissue 
1. 
Atherosclerosis
The endothelial cells that line the lumen of a healthy artery regulate the trans-
port of nutrients, signaling molecules and other substances between the blood 
and the vessel wall by adjusting their degree of permeability in response to sys-
temic or mechanical cues. Dysfunction of endothelial cells primes the arterial 
wall for atherosclerosis 2. Endothelial dysfunction can be triggered by mechani-
cal factors, which will be discussed in the next paragraph, and can be enhanced 
by a variety of risk factors such as lifestyle, e.g. smoking, diabetes and physical 
inactivity, and/or genetic factors 3. Endothelial dysfunction results in increased 
vascular permeability which enables circulating lipoproteins, in particular low 
density lipoprotein (LDL), from the blood to accumulate in the intima. Lipopro-
teins are transport vehicles for lipid molecules, composed of a protein-enfor-
ced, hydrophilic outer membrane and a core of hydrophobic lipid molecules. 
Major lipid components of the lipoprotein core are cholesteryl esters and tri-
glycerides, while the membrane consists of a monolayer of phospholipids and 
free cholesterol. The influx of lipoproteins and their eventual aggregation and 
oxidative modification attracts circulating monocytes, that transmigrate into 
the intima and subsequently transform into macrophages 4–6. The macrophages 
internalize the accumulated lipoproteins with the aim of converting and excre-
ting the sterol lipids as solubilized esterified lipid droplets 7,8. However, if too 
much lipid accumulates in the arterial wall, this cellular conversion system can-
not keep pace and the macrophages turn into lipid-laden foam cells. Apoptosis 
of these foam cells and the resulting spill of their lipid contents into the tissue, 
forming so-called necrotic cores or lipid pools, exacerbates instead of resolves, 
the pathogenic process 3,4. The intimal lesion that is formed by this process is 
called ‘plaque’. At the same time, the interaction of lipoproteins and lipopro-
tein-derived lipids with immune cells such as macrophages can induce a wide 
array of signaling pathways that are not exclusively pro-atherogenic 7. Over 
the course of disease progression, the size of the plaque can increase and its 
compositional complexity 9 and lipid content 5,6,8,10 can change. Disease stages 
were classified histologically and were found to vary from pathological intimal 
thickening to thin fibrous cap atheroma 3,11,12. The first stages of atherosclerotic 
disease are characterized by thickening of the intima, foam cell infiltrates and 
small extracellular lipid pools. More advanced plaques contain larger necrotic 
cores which are shielded from the blood by a fibrous layer, i.e. the cap, and 
these plaques may contain calcifications, cholesterol crystals and/or neovas-
cularization. Several processes can result in thinning and/or weakening of the 
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fibrous cap, rendering the cap at risk of rupture. Cap rupture causes the release 
and subsequent embolization of plaque contents into the circulation, which can 
lead to cerebrovascular or cardiovascular events, depending on the anatomical 
location of the plaque. Based on the rupture risk, plaques can alternatively be 
referred to as stable, i.e. fibrous tissue-rich, or vulnerable, i.e. containing large 
cores of lipids and necrotic debris covered by a thin cap. 
Hemodynamics and disease initiation and progression
Wall shear stress and plaque initiation
Mechanical factors induce endothelial dysfunction, driving the pattern in which 
early atherosclerotic plaques appear over the vascular tree. Bends and bifurca-
tions of the arterial system are so-called predilection sites for atherosclerosis. 
This phenomenon can be attributed to wall shear stress (WSS), the frictional 
force exerted by the flowing blood on the endothelial cells. Endothelial cells 
contain mechanosensitive structures e.g. cell surface receptors, that sense 
patterns and levels of WSS and that respond to it by regulating intracellular 
signaling cascades that regulate several processes, including vessel diameter 
13,14. Via this mechanism physiological WSS values can be retained, even when 
the amount of blood flow alters. Physiological values of WSS, i.e. around 1 Pa, 
are atheroprotective: they induce a quiescent, anti-inflammatory state in endo-
thelial cells. Low and/or oscillatory WSS values however, elicit endothelial cell 
activation and a pro-inflammatory state 15,16. Because vessel geometry influen-
ces WSS patterns, bends and bifurcations in the arterial tree are exposed to low 
and/or oscillatory WSS and thus predisposed for lesion initiation. Upon activa-
tion, endothelial cells lose their aligned appearance and enter a pro-atheroge-
nic state, characterized by increased activation of pro-inflammatory signaling 
pathways, resulting in increased adhesion molecule expression to bind immune 
cells, increased oxidative stress and increased permeability 2,15. 
The carotid arteries are prone to develop plaques
One of the predilection sites for lesion initiation is the carotid bifurcation. The 
human body contains two carotid arteries, which accommodate the bulk of 
the blood transport from the aorta to the head. The part of the carotid artery 
proximal to the aorta is called the common carotid artery (CCA). The CCA bifu-
rcates into the internal carotid artery (ICA), which delivers blood to the brain, 
and the external carotid artery (ECA), which supplies the face. The geometry 
of the carotid bifurcation region induces low and oscillatory WSS patterns, and 
subsequent priming for plaque initiation, at the lateral walls of the bifurcation 
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and in the ICA (Fig. 1 17). Plaque initiation and development at the carotid arte-
ry can be seen in all people and already at a young age 18. As the carotid artery 
is a large and superficial artery, it is easily accessible for imaging and surgical 
intervention. This renders the carotid arteries a widely studied anatomical 
location for investigating atherosclerosis initiation and progression in relation 
to WSS. 
Fig. 1: The anatomy of the carotid arteries. The common carotid artery (CCA) bifurcates 
into the internal carotid artery (ICA) and external carotid artery (ECA). This bifurcation 
region is susceptible to atherosclerotic plaque development. Figure adapted from 17 
Computation of WSS
There is no method to directly measure WSS in vivo. However, there are ways 
to derive WSS values based on direct measurements of other hemodynamic 
parameters and vessel geometry. The most accurate way is using computati-
onal fluid dynamics (CFD). This is a computational method in which the Na-
vier-Stokes equations, which describe the behavior of fluid, are numerically sol-
ved. The method requires an accurate reconstruction of the artery geometry, 
in our case the carotid bifurcation region, discretized into a mesh of very small 
elements. Additionally, the fluid properties of the blood, such as the viscosity 
and density, need to be described. These values are often based on populati-
on-averages reported in literature. Third, the physical boundary conditions, i.e. 
measures of the blood flow at the in- and outlet regions of the geometry, need 
to be defined. Both the artery geometry and the boundary conditions neces-
sary for CFD can be obtained by imaging. For this purpose, imaging of carotid 
arteries is often performed by magnetic resonance imaging (MRI). When all 
required input values have been set, the Navier-Stokes equations can be solved 
in an iterative manner. These CFD simulations, implemented in commercial 
software packages, result in a description of the velocity and pressure of the 
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fluid in all directions, which are used to calculate WSS.
WSS and plaque progression
Though WSS is considered a relatively well-established factor in plaque initia-
tion, its contribution to plaque progression is less clear. Plaque growth is ini-
tially accompanied by outward or expansive vessel remodeling, which ensures 
preservation of lumen diameter and consequently sustainment of the low WSS 
levels 18,19. At a relative plaque area of around 40% however, a plaque generally 
starts to encroach the lumen and this lumen narrowing can locally induce an 
increase in WSS in case of unaltered flow rates 18. This increased WSS might 
consecutively alter endothelial cell signaling and influence plaque progression 
20. Thus as atherosclerosis progresses, the interplay between WSS and plaque 
progression becomes interdependent and this relation remains to this day not 
fully elucidated 20,21. Finding a correlation between WSS and compositional 
characteristics of advanced atherosclerotic plaques is relevant for understand-
ing disease pathophysiogy, but might also add predictive value to the current 
set of prognostic markers for plaque vulnerability, thereby improving diagnosis 
and treatment strategy. The next paragraph provides an overview of the cur-
rently available models and knowledge regarding this matter.
Investigating WSS and atherosclerosis in the carotid arteries
In order to elucidate the relation between WSS and plaque progression, differ-
ent animal models of surgically-induced atherosclerosis have been developed 
22. An example is the placement of a tapering cast around the CCA of mice, 
to induce altered WSS patterns and accelerate atherosclerosis progression 23. 
Animal models provide a controllable environment in which WSS and plaque 
development can be monitored over time. This availability of WSS metrics and 
plaque information at multiple time points is an important advantage of animal 
models. In human subjects, on the other hand, WSS and plaque composition 
have been investigated mostly by cross-sectional studies involving only one 
time point. To this end, a wide array of imaging studies, mostly using MRI, 
ultrasound or Computed Tomography (CT), have been performed to assess the 
association between atherosclerosis and WSS in the carotid artery in humans, 
both in asymptomatic and symptomatic patients. In these studies, WSS was 
correlated to compositional features of plaque vulnerability, e.g. wall thickness, 
lipid pool size, presence of intraplaque hemorrhage, ulcer and/or inflammatory 
markers 24–32. The composition of an advanced plaque was found to vary over 
its axial length and the site of maximal lumen narrowing was not necessarily 
the plaque’s most vulnerable location. That is, ulceration, a strong independent 
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predictor of stroke 33–35, and associated with plaque rupture 36, has been en-
countered predominantly upstream of the minimal lumen area 29,37–39 and also 
occurs in hemodynamically insignificant stenosis 33,37. Also, the cellular com-
position was shown to alter over the axial length of the plaque, with a higher 
abundancy of macrophages and proteolytic and pro-apoptotic factors, assumed 
to cause cap thinning, at the high shear stress-exposed upstream site 28,40. The 
inhomogeneous morphology and composition of advanced plaques suggests 
a relation between local hemodynamics and plaque composition. Histology 
is the current gold standard for assessing plaque composition in high resolu-
tion. However, the one-to-one relation between local WSS levels and histolo-
gy-based plaque composition has not been performed yet in a substantial set 
of cases of advanced atherosclerosis.
Identification of the vulnerable, rupture-prone plaque
Most research into the pathophysiology of atherosclerosis is ultimately aimed 
at identifying the vulnerable plaque based on tissue compositional or hemo-
dynamic parameters. At the same time, development of imaging strategies to 
visualize these plaque characteristics indicative of vulnerability is ongoing 41. 
Besides the potential of WSS as a marker for plaque vulnerability, which is co-
vered in the first part of this thesis, we also investigate the plaque’s lipid com-
position in relation to histological markers of vulnerability. Namely, as the lipid 
molecules incorporated into the plaque have been shown to reflect disease 
stage 5,6,8,10, studying this lipid composition will be informative for plaque phe-
notyping and risk assessment. In vivo, the spectral lipid signal can be visualized 
by imaging modalities like spectral photoacoustics 42, making the lipid profile of 
a plaque a potential powerful imaging biomarker.
Imaging of lipids by MALDI-MSI
A suitable imaging modality for visualizing lipids in tissue sections is matrix-as-
sisted laser desorption/ionization mass spectrometry imaging (MALDI-MSI) 
43. This method requires deposition of a matrix on the tissue section, which, 
upon laser irradiation, promotes the desorption and ionization of the tissue 
molecules 44,45. Depending on the chosen ionization mode of the MALDI source, 
positive or negative analyte ions are formed, which enter the mass spectro-
meter. Ionization using MALDI produces single-charged ions and does not 
elicit in-source molecular fragmentation, which is very advantageous for the 
measurement of lipids 43,46. The chosen matrix and ionization mode determine 
the type of lipids that can be measured: using positive polarity e.g. phosp-
hocholines, sphingomyelins and triglycerides can be detected, while in negative 
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mode e.g. phosphatidylinositols or phosphatidylethanolamines are seen 47. In 
the mass spectrometer, the ions are sorted by their mass-to-charge (m/z) ratio. 
The measurement output is described by a mass spectrum, which reports the 
measured molecular masses and their relative intensities. In mass spectro-
metry imaging (MSI) a mass spectrum is captured for each pixel of the tissue 
section. In this way, a multi-dimensional dataset is collected, containing both 
spatial and mass spectral information. Tissue sections imaged by MALDI-MSI 
can, after matrix removal, be stained histochemically. Using accurate image 
registration, the spatial lipid data captured by MALDI-MSI can be correlated to 
tissue compositional features identified by histology. 
Aim and outline of this thesis
This thesis is aimed at visualizing hemodynamic and tissue compositional 
patterns in atherosclerotic carotid bifurcations. The first part of this thesis is 
focused on the distribution of WSS and its correlation with histologically-deter-
mined compositional characteristics of plaque vulnerability. In Part II, spatial 
lipid patterns in advanced carotid plaques are investigated. We compare these 
lipid distributions to compositional characteristics of plaque vulnerability with 
the aim of finding lipid signatures that help to identify the vulnerable plaque. 
PART I: Hemodynamics and plaque vulnerability
Chapter 2 describes an image-registration pipeline to register WSS data and 
corresponding histological images of human carotid plaques. The WSS data is 
calculated from in vivo MR imaging and computational fluid dynamics. Using a 
series of rigid and non-rigid registration steps, in conjunction with intermediate 
imaging modalities to capture tissue deformations inferred by plaque excision 
and histological processing, we map WSS values on the corresponding histo-
logical lumen contours. This method enables correlation of local WSS to the 
histological composition of the underlying plaque tissue. 
In Chapter 3, we apply this registration method on a set of human carotid 
atherosclerotic plaques. We calculate time averaged WSS (TAWSS) patterns 
as well as oscillatory shear index (OSI) patterns and investigate the correlated 
histological plaque composition at different tissue depths. NC size was found 
to be significantly higher at high TAWSS regions and macrophage area and cap 
thickness were higher at regions exposed to low OSI. 
Chapter 4 describes a mouse model in which atherosclerosis is induced by cast 
placement in the common carotid artery. WSS distribution and disease deve-
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lopment are monitored at multiple time points. This longitudinal study shows 
the temporal and spatial changes in WSS patterns during plaque progression. 
At the final time point, the correlation between WSS and histological plaque 
composition is assessed.
PART II: Lipid imaging in atherosclerosis
We developed a pipeline for visualizing the spatial distribution of lipids by 
MALDI mass spectrometry imaging. Chapter 5 describes how tissue processing, 
MALDI measurement parameters and data analysis were optimized to obtain 
a reproducible and ready-to-use pipeline for lipid imaging in human carotid 
atherosclerotic plaques. In a set of tissue sections, we investigate the correlati-
on between spatial lipid distributions and histological plaque characteristics.
In Chapter 6 the lipid imaging pipeline is applied to a dataset of human carotid 
endarterectomy samples. We analyze the resulting highly dimensional dataset 
both by a clustering algorithm as well as by a histology-based multivariate ana-
lysis. We report increased abundances of sphingomyelins and oxidized chole-
steryl esters in necrotic core regions, as well as spatial correlations between 
diacylglycerols and triacylglycerols with thrombotic tissue.
The main findings in this thesis are discussed in Chapter 7. We discuss the 
added value of our findings to the atherosclerosis research field and the future 
developments that might be at hand.
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Abstract
Wall shear stress (WSS), the frictional force exerted on endothelial cells by 
blood flow, is hypothesized to influence atherosclerotic plaque growth and 
composition. We developed a methodology for image registration of MR and 
histology images of advanced human carotid plaques and corresponding WSS 
data, obtained by MRI and computational fluid dynamics. 
The image registration method requires four types of input images, in vivo MRI, 
ex vivo MRI, photographs of transversally sectioned plaque tissue and histology 
images. These images are transformed to a shared 3D image domain by ap-
plying a combination of rigid and non-rigid registration algorithms. Transforma-
tion matrices obtained from registration of these images are used to transform 
subject-specific WSS data to the shared 3D image domain as well. WSS values 
originating from the 3D WSS map are visualized in 2D on the corresponding 
lumen locations in the histological sections and divided into eight radial seg-
ments. In each radial segment, the correlation between WSS values and plaque 
composition based on histological parameters can be assessed.
The registration method was successfully applied to two carotid endarterec-
tomy specimens. The resulting matched contours from the imaging modalities 
had Hausdorff distances between 0.57 and 0.70 mm, which is in the order of 
magnitude of the in vivo MRI resolution. We simulated the effect of a mismatch 
in the rigid registration of imaging modalities on WSS results by relocating the 
WSS data with respect to the stack of histology images. A 0.6 mm relocation 
altered the mean WSS values projected on radial bins on average by 0.59 Pa, 
compared to the output of original registration. This mismatch of one image 
slice did not change the correlation between WSS and plaque thickness. In 
conclusion, we created a method to investigate correlations between WSS and 
plaque composition.  
Introduction
Atherosclerosis is a progressive vascular disease, characterized by the accu-
mulation of lipids and inflammatory cells in the vessel wall, which results in 
plaque formation.  A subset of atherosclerotic plaques is prone to rupture 
1-3. A rupture-prone, vulnerable plaque differs compositionally from a stable 
plaque, and is characterized by a large lipid core covered by a thin fibrous cap, 
inflammatory cell infiltration and/or intraplaque haemorrhage. In the event of 
rupture, plaque- and thrombus material may embolize into the distally located 
vessel bed. Depending on the anatomical location of the plaque, rupture might 
lead to stroke or acute myocardial infarction. Unravelling the mechanisms be-
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hind plaque destabilization, leading to a rupture-prone plaque, is thus of high 
importance. 
Wall shear stress (WSS) is the blood-exerted frictional force on the vessel wall. 
Low and/or oscillatory WSS is an established factor in atherosclerosis initiati-
on, due to activation of pro-inflammatory pathways in the endothelium. The 
pro-inflammatory environment favors oxidation and retention of lipoproteins 
inside the vessel wall, aggravating inflammation and resulting in atherosclerotic 
plaque formation 4-6. 
In case of advanced lumen-intruding plaques, the influence of WSS on the 
human plaque composition and thus vulnerability is still a subject of debate. 
Several invasive imaging studies have assessed plaque size and corresponding 
WSS levels 7-9 while other studies included surrogate markers of plaque vulne-
rability, such as plaque burden 10-14, intraplaque hemorrhage 15,16, inflammation 
17, lipid core size 18 or plaque stiffness 19. However, none of these studies were 
able to fully characterize plaque vulnerability as histology is regarded as the 
gold standard for assessment of local plaque vulnerability. Thus, our research 
question requires co-registration of 2D histology information with MR imaging 
and its derived WSS data. Co-registration of imaging modalities is challenging, 
as the registration method has to account for tissue reorientation and defor-
mation occurring due to multimodal imaging and tissue processing. Different 
approaches of registering histology sections and 3D medical imaging such as 
MRI have been proposed, varying from slice-to-slice approaches, slice-to-vo-
lume approaches, volume-based approaches and hybrid methods. Also, extra 
imaging modalities, such as ex vivo tissue scans and/or blockface photographs, 
have been added to registration frameworks to refine registrations and account 
for tissue processing artefacts 20. Multiple methods for co-registration have 
been described in an extensive review 20. 
To assess the relation between WSS and plaque composition from histology, 
we based our image registration method on a previously designed tool 21 to 
map 2D histological cross-sections of a human carotid plaque to the 3D in vivo 
artery geometry. 21-23. In our method, the registration of histology and in vivo 
MRI/WSS data was aided by an additional ex vivo MR scan and block photo-
graphs (en face) of sliced tissue. The novelty of the method presented here, lies 
in  the use of subject-specific geometries and flow data obtained by in vivo MR 
imaging, making the image registration framework fully based upon MRI data.
In this paper, the new image registration method is described and tested on 
two human carotid plaques. Moreover, we simulated the effect of a registration 
mismatch between imaging modalities on WSS results to evaluate the impact 
of a potential mismatch on WSS and correlations between WSS and plaque 
thickness.
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Methods 
Plaque MR imaging
In vivo MR imaging
Two patients scheduled for elective carotid endarterectomy for recent stroke 
or transient ischemic attack, underwent an MRI scan one day prior to surgery. 
The carotid plaques were imaged in vivo in order to visualize lumen and outer 
wall geometry and measure blood flow velocity.  Patients were scanned in a 
3.0 T MRI scanner (General Electric (GE) Healthcare, Milwaukee, USA) using a 
four-channel phased-array coil with an angulated setup (Machnet B.V., Roden, 
The Netherlands). Lumen and plaque geometry were imaged using a black 
blood 3D fast spin echo (3D-BB-FSE) sequence with variable flip angles (TR/TE: 
1000/16 ms, FOV: 15 cm, slice thickness: 0.8 mm, matrix: 160x160, number 
of excitations 1, scan time: 190 s). The MRI scan was resampled to a resolu-
tion of 0.4 x 0.4 x 0.6 mm. Blood flow velocity was measured at 2 locations, 
approximately 20 mm below and ~20 mm above the carotid bifurcation, using 
3D phase-contrast MRI (TR/TE: 5/3 ms, FOV: 15 cm, slice thickness: 4.0 mm, 
matrix: 160x160, scan time: ~3 min, VENC: 70 cm/s). Written informed consent 
was obtained. This study was approved by the Medical Ethical Committee of 
Erasmus MC.
Plaque tissue collection and ex vivo MR imaging
Carotid plaque specimens, hereafter referred to as ‘CEA1’ and ‘CEA2’, were 
collected within 30 minutes after surgical resection. Plaque tissue was resected 
with a specialized technique, resulting in tissue specimens with intact lumen 
and plaque morphology 24. Tissue was rinsed with phosphate-buffered saline 
(PBS), snap frozen in liquid nitrogen and stored at -80 °C until further proces-
sing. 
Ex vivo T2w fast recovery FSE (frFSE)MRI scans (TR/TE: 2500/66 ms, in-plane 
resolution: 0.1 x 0.1 mm, slice thickness: 0.5 mm, matrix: 256x256, scan time: 
~20 min, number of slices: 66) of the excised CEAs provided necessary images 
of the plaque to link histology and in vivo MRI images in the registration pro-
cedure. Ex vivo MR imaging was performed on 4% formaldehyde-fixed plaque 
specimens, immersed in PBS, with a 7.0T MRI scanner (7.0T Discovery MR901, 
GE Healthcare, Milwaukee, USA).
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Specimen processing, en face photos and analysis
Formaldehyde-fixed CEA tissue was decalcified in a solution of 10% ethylenedi-
aminetetraacetic acid (EDTA) in demineralized water for 14 days, washed in 
PBS and cut in 1 mm consecutive transverse sections. The proximal side of each 
transverse section was photographed (IXUS 60, Canon, Tokyo, Japan). Photos, 
hereafter referred to as ‘en face photos’, were taken from a fixed point per-
pendicular to the tissue section. The tissue section was further processed and 
embedded in paraffin. The en face photo contained landmarks to enable the 
registration of this photo to the en face photo of the adjacent transverse secti-
on, as well as a measuring grid to calculate the image resolution. The paraffin 
blocks were sectioned into 5 µm sections, which were stained histochemically 
(Hematoxilyn-Eosin stain and Miller’s Elastic stain). Lumen and intima were 
segmented on the Miller’s Elastic stain (Fig. 1), using an in-house developed 
software tool (Mevislab 2.7.1, MeVis Medical Solutions, Bremen, Germany). 
Size of plaque components was expressed in mm2.
Computational fluid dynamics
Lumen contours were segmented from the MRI 3D-BB-FSE scan using ITK-SNAP 
software 25. A volume mesh of approximately 4 million tetrahedral and prism 
elements was generated using ICEM (ANSYS ICEM, 17.1, ANSYS, Pennsylvania, 
USA). The patient-specific time-dependent blood velocity profile in the com-
mon carotid artery (CCA) was derived from the phase-contrast MRI scan using 
MATLAB (MATLAB R2015b, Mathworks Inc., Natick (MA), USA) and applied 
as inlet boundary condition 26. As outlet boundary condition we assumed the 
outflow ratio of the internal carotid artery (ICA) and external carotid artery 
(ECA)  to be 50:50, corresponding to moderately stenosed carotid bifurcations 
27.  According to previously defined protocols, blood density was set to 1060 
kg/m3 and non-Newtonian fluid behavior was mimicked by the Carreau-Yasuda 
model 26. The Navier-Stokes equations were solved and time-dependent wall 
shear stress (WSS) was computed using Fluent software (ANSYS Fluent, 17.1, 
ANSYS, Pennsylvania USA) over the length of two heart cycles with a time step 
of 0.004 seconds. The results of the second heart cycle were used for analysis 
to account for entrance effects. 
Image registration
In order to register 2D histology images to the 3D shear stress distribution, we 
adapted an image registration tool that was developed to register in vivo CT 
images to histology 21. 
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We aimed at mapping histology images, en face photos, ex vivo MRI and in 
vivo MRI, as well as the WSS data to a shared 3D image domain. We chose the 
image domain of the en face photos as the shared domain. To that aim, MRI 
scans and WSS data were resampled and transformed to the en face image 
domain by the series of registration steps explained below and shown in Fig. 2. 
The z-resolution of en face and histology was equal, since each en face photo 
had a corresponding histology section. Thus by choice of the shared en face 
image domain, interpolation of histology images in z-direction could be avoid-
ed and only in-plane registrations were necessary to transform histology to the 
shared image domain. Coordinate transformations that describe mappings of 
the different imaging modalities were obtained in a series of registration steps. 
An overview of the registration procedure is shown in Fig. 2. 
A 3D reconstruction of the excised vessel was created by stacking the en face 
photos of adjacent transverse sections, using point-based rigid registration 
based on applied landmarks. In this way, we obtained a 3D stack of en face 
photos. Subsequently, in vivo MRI, ex vivo MRI and histology images were 
mapped to the 3D stack of en face photos via a series of registration steps. We 
started with rigid registration of in vivo MR images to ex vivo MR images, by 
determining corresponding points on the first slice cranial to the bifurcation in 
both image sets (Fig. 2, step A, blue arrow). This was the first MR slice in which 
both the internal and the external carotid artery were visible. Based on these 
points and using a similarity transformation, i.e. rotation and isotropic scaling, 
the in vivo MR images were transformed and resampled to the ex vivo image 
domain using the Elastix toolbox 28. We assumed the deformation of the plaque 
in longitudinal direction after surgical resection to be minimal, as the tissue 
was relatively stiff and was resected in intact shape. After rigid registration, 
an additional B-spline deformation model was applied to the transformed and 
resampled in vivo MR images to improve the mapping to the ex vivo MR images 
28. To that aim, contours of the lumen and outer wall were drawn in both image 
sets. A non-rigid B-spline transformation (metric: advanced mean squares, op-
timization: adaptive stochastic gradient descent 28) was applied to match the in 
vivo contour sets to the ex vivo contours (Fig. 2, step A, red arrow). The coordi-
nate transformation resulting from this non-rigid registration step was applied 
to the in vivo MR images that were already rigidly registered to the ex vivo 
images. Thus, with the aid of a similarity and a B-spline transform, the in vivo 
MR images were mapped to the ex vivo image domain The ex vivo MR images 
were registered to the 3D stack of en face photos (Fig. 2, step B) using a similar 
rigid and non-rigid registration procedure. Based on anatomical landmarks, 
histological sections were registered and transformed to their corresponding 
section in the 3D stack of en face photos using a similarity transformation (Fig. 
2, step C). This resulted in a 3D stack of histology images. Taken together, this 
set of registration steps provided us with the necessary coordinate transforma-
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tions to map the WSS data and the in vivo MR images to the 3D stack of en face 
photos as well.
Data processing, selection and analysis
For data analysis, WSS values originating from the 3D WSS map were visualized 
in 2D onto the corresponding lumen locations in the histological sections using 
nearest-neighbor interpolation. Therefore, WSS values were averaged in axial 
direction over a region of -0.3 mm to +0.3 mm with respect to the z-location of 
the histological section (Fig. 3A). This axial length corresponded to the axial res-
olution of the in vivo MRI scan. In-plane, the cross-section was subdivided into 
8 radial segments and the WSS values were averaged 29. The centerpoint that 
served as origin for the radial segmentation, was obtained from the centerline 
of the transformed 3D WSS map. This centerline was obtained using the cen-
terline algorithm in VMTK software 30 which makes use of the Voronoi diagram 
of the vessel model. The centerline calculation is based on the radii of maximal-
ly inscribed spheres along the path of the Voronoi diagram 31. An example of 
a histological image with manually segmented areas and distribution of radial 
bins is shown in Fig. 1.
Radial bins were eliminated from the dataset on the basis of three types of 
errors: 1) presence of processing artefacts in histology, 2) mismatch between 
histology and en face photos due to inhomogeneous shrinkage or strain in the 
tissue that could not be accounted for in the registration procedure, and 3) 
mismatch in registration between in vivo MR images and en face photos. The 
presence of all error types was visually assessed by three independent obser-
vers. Radial bins were excluded based on consensus. The effect of the exclusion 
of type 2 and type 3 error-containing bins was investigated with the following 
metrics: 1) by calculating the Dice Similarity Coefficient (DSC)  between lumen 
segmentations in the en face photos and histology images (type 2 error, DSC_
type2) and in the en face photos and transformed in vivo images (type 3 error, 
DSC_type3) and 2) by calculating the Hausdorff distance (HD) between the 
edges of the lumen segmentations in the en face photos and histology images 
(HD_type 2) and in the en face photos and in the transformed in vivo images 
(HD_type3). For each radial segment, mean, maximum and minimum WSS (Pa) 
and average plaque thickness (mm) were calculated. Plaque thickness was de-
fined as the mean shortest distance between the lumen border and the lamina 
media border in histology images.
Simulation of image registration mismatch
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This procedure used a combination of imaging modalities and multiple registra-
tion steps to enable reliable registration of WSS data to histology. We investiga-
ted the effect of a potential registration mismatch in the order of magnitude of 
the in vivo MR resolution on mapped WSS values. To that aim, we relocated the 
WSS data with respect to the stack of histology slices. We simulated mismat-
ches in rigid registration of a complete axial in vivo MRI slice, i.e. a relocation 
of WSS data by -0.6 mm or +0.6 mm, and a mismatch of half the axial in vivo 
MRI resolution, i.e. -0.3 mm and +0.3 mm (Fig. 3). We subsequently analyzed 
the resulting change in WSS value projected on each radial histology bin. The 
effect of registration mismatches on the possible correlation between WSS 
and plaque thickness was also investigated by plotting, for each radial bin, the 
mean, minimum and maximum WSS against the average plaque thickness and 
calculating the Pearson correlation coefficient R.
Statistical analysis
WSS values projected on radial bins, after different relocation distances of the 
WSS stack, were compared to the original WSS-histology registration using a 
Wilcoxon signed rank test. For each relocation case, the correlation between 
WSS and plaque thickness per radial bin was calculated (MATLAB R2015b, Ma-
thworks Inc., Natick (MA), USA) at a 0.05 significance level.
Figure 1: Result of manual segmentation of lumen and intima areas and definition of 
radial bins. A) Image of an histology section (Miller’s Elastic Stain) of caudal side of an 
endarterectomy specimen. Plaque components are visualized: * necrotic core, • calcium, 
# hemorrhage. B) Segmentation of intima and lumen area and radial bins. Based on the 
centerline, eight radial bins were defined. Mean WSS per radial bin was calculated.
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Imaging modality
Image domain WSS
in vivo
ex vivo
en face
histology
WSS in vivo ex vivo en face histology
Rigid (similarity transform)
Non-rigid (B-spline transform)
Image registration
Image transformation
Rigid (similarity transform)
Non-rigid (B-spline transform)
A
B
C
Figure 2: Image registration overview. Black dots represent the original image domains 
of the different imaging modalities. White dots represent the image domain where 
the corresponding imaging modality is mapped to using rigid (blue arrows) and non-
rigid (red arrows) transformations. Image sets are brought to a mutual image domain, 
the en face photos. Step A represents the registration of in vivo MRI to ex vivo MRI. 
Step B represents the registration of ex vivo MRI to en face photos. The coordinate 
transformations obtained in registration step A and B can also be used to map the WSS 
data to the image domain of the en face photos. Step C represents the registration and 
transformation of histology images to the en face image domain.
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Figure 3: Projection of WSS data on histology (A) and simulation of image registration 
mismatch (B).  A illustrates the relation between WSS data, which is continuous in 
z-direction, and the 3D reconstructed stack of histology sections, which are spaced 1mm 
in z-direction. For analysis of the correlation between WSS and histology, WSS data 
needed to be averaged in z-direction and mapped and correlated to the nearest histology 
image. WSS data was averaged in z-direction over a region of -0.3 mm to +0.3 mm with 
respect to the z-location of the histological section. B illustrates how the WSS data was 
relocated with respect to the histology stack to simulate a mismatch in registration.
Results
Plaque imaging, specimen processing and image registration
12 sets of WSS-histology images, representing 12 axial locations, were included 
for CEA1 and 11 sets of images for CEA2. In Fig. 4 shows some examples of 
histology slices with the transformed WSS data visualized on the lumen.
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Figure 4: Histology images with WSS data projected onto the lumen. This figure 
illustrates the mapping of histology sections and WSS data to the shared image domain 
by the series of registration steps. When brought into the same image domain, WSS 
data, averaged in axial direction, can be projected onto the lumen of the corresponding 
histology section.
Data processing, selection and analysis
We segmented the lumen and intima contours on all histological sections 
included in the analysis. Using the centerline as origin, eight radial bins were 
projected onto a histological section. This resulted in (12+11)*8=184 radial bins 
in total. Per radial bin, we checked whether histological processing errors (type 
1) or registration errors (type 2 and 3) were present. In Table 1 the number 
of excluded radial segments after image registration on the basis of different 
errors is summarized for CEA1 and CEA2. Note that some bins present with 
multiple type of errors. 
In both CEAs, the majority of exclusions of radial bins were due to type 1 errors 
(37 of 184 bins), representing histological artefacts. Errors of type 2 and 3, 
representing registration mismatches between imaging modalities were found 
in a small number of bins: 19 of 184 bins had a type 2 error and 13 of 184 bins 
were found to have a type 3 error. Excluding these bins, based on consensus 
between three observers, improved the mean DSC and HD values for both 
CEAs (Table 1). The average DSC_type2 became 0.82 for both CEAs. The aver-
age DSC_type3 became 0.90. The average HD for both CEAs was 0.70 mm after 
exclusion of bins on basis of type 2 errors. After exclusion of type 3 error-con-
taining bins, average HD reduced to 0.57 mm. 
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Table 1: Exclusion of radial bins on basis of three types of registration error.
Type 1 error
Type 2 error
Type 3 error
Rem
aining 
radial bins
Number 
of bins
Number 
of bins
Mean 
DSC and 
HD*
Number 
of bins
Mean 
DSC and 
HD* 
CEA1 24 8 DSC: 0.78 
vs. 0.83**
HD: 1.06 
vs. 0.65
5 DSC: 
0.79 vs. 
0.90**
HD: 1.01 
vs. 0.59
73/96 
(76.0%)
CEA2 13 11 DSC: 0.70 
vs. 0.81**
HD: 1.23 
vs. 0.75 
8 DSC: 
0.84 vs. 
0.89**
HD: 0.87 
vs. 0.55
60/88 
(68.2%)
*DSC = Dice Similarity Coefficient, HD = Hausdorff Distance (mm)
**Mean DSC and HD values are given before vs. after exclusion of bins with error
Simulation of image registration mismatch
The WSS data was relocated by -0.6 mm, -0.3 mm, +0.3 mm and +0.6 mm 
(Fig. 3B) in z-direction, with respect to the stack of histology images. For each 
registration case, the mean WSS value per radial histology bin was calculated. 
For each axial location, the WSS values of the radial bins were averaged. In Fig. 
5, the distribution of WSS values over axial locations for each case of relocation 
of the WSS data is visualized for CEA1 and CEA2 and compared to the original 
registration. The deviation between WSS values in the original registration and 
WSS values in cases of simulated registration mismatch increased with increas-
ing length of axial mismatch. Combining the results of both CEAs, mean WSS 
varied on average 0.25 Pa in case of 0.3 mm relocation and 0.59 Pa in case of 
0.6 mm relocation. In none of the cases the difference in mean, minimum or 
maximum WSS after relocation, with respect to the WSS values of the original 
registration, were significant.  We tested the effect of relocation of the WSS 
data on the correlation between WSS and plaque thickness. Per axial location, 
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we plotted, for each radial bin, the mean, minimum and maximum WSS against 
the average plaque thickness and calculated the R value of the original registra-
tion. In two axial locations, the correlation between minimal WSS and plaque 
thickness was negative and significant. In all other axial locations, no significant 
correlation between plaque thickness and mean, minimum or maximum WSS 
was found. Considering the negative correlation between WSS and plaque 
thickness found in one axial location: this correlation remained significant in all 
cases of 0.3 mm relocation and in two out of four cases of 0.6 mm relocation. 
Fig. 6 shows the results of this analysis for one axial location. After relocating 
the WSS data, the R value of the original registration (R = -0.90) increased to R 
= -0.97 after application of a +0.6 mm relocation of the WSS stack (Fig. 6). The 
R value decreased to R = -0.83 when a –0.6 mm relocation was applied (Fig. 6). 
In this example, significance was lost only in case of -0.6 mm relocation of WSS 
data. A mismatch of 0.3 mm changed the value of the correlation coefficient 
between mean WSS and plaque thickness by 0.045 on average. A mismatch of 
0.6 mm changed the correlation coefficient between mean WSS and plaque 
thickness by on average 0.049, compared to the original registration.
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Figure 5: Average absolute variation in mean, minimum and maximum WSS values 
for axial locations after relocation of WSS data in CEA1 and CEA2. Delta represents 
difference in WSS value compared to original rregiststration. Note that the Y-axis scaling 
differs in the Δmax WSS boxplot.
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Figure 6: Correlation between minimal WSS and plaque thickness for one axial 
location. Variation in minimum WSS-plaque thickness correlation, resulting from 
relocation of the WSS data in z-direction, is shown.
Discussion
We developed the first MRI-based pipeline to register WSS data to histology 
images. This method enables patient-specific investigation of correlations 
between WSS and histology-based plaque composition. We demonstrated that 
a mismatch of one slice does not significantly affect WSS distribution or the 
relation between WSS and plaque thickness.  
In terms of image registration, this pipeline is an improvement over a previous 
CT-based method developed by our group 21. Our new pipeline is fully based 
on MRI, and therefore requires less image registration steps. Compared to CT, 
in vivo MR imaging is less harmful to the patient as it does not involve ionising 
radiation. In addition, patient-specific blood flow and WSS information can 
be derived from MRI scans 26. Finally, MR imaging has the potential to image 
different plaque components 32, that can serve as additional landmarks for 
image registration, in addition to the lumen and vessel wall contours used in 
this pipeline. 
In addition to our objective of registering WSS data to histology, the developed 
image registration method can also serve other MRI-based image registration 
purposes, such as comparison of plaque imaging sequences or validation of 
image segmentation algorithms.
We assessed registration accuracy and excluded radial bins on the basis of 
three error types. By this selection process, 28% of radial bins was excluded 
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from the data-sets. Only a minor part of radial bins was excluded due to insuf-
ficient image registration, as represented by type 2 and type 3 errors. Reliable 
matching between histology and WSS was also evaluated by DSC and HD. After 
removing insufficiently matched radial bins from the data-sets, average HD 
values ranged from 0.57 mm to 0.70 mm. This distance between en face photo 
contours and histology or WSS contours was in the order of magnitude of the 
in vivo MRI resolution.
The applied image registration algorithms required user-defined matching of 
the bifurcation slices and segmentation of lumen and outer wall contours in 
different imaging modalities. However, image registration accuracy might be 
compromised for plaque samples with a relatively large axial length and/or a 
concentric plaque. In these cases, accuracy of the pipeline can be improved 
if rigid registration can reliably be based on multiple image slices. To achieve 
this, additional anatomical landmarks are needed, that are clearly recognizable 
in the imaging modalities to be registered. Large calcium spots might be good 
landmarks, as these can be imaged by a combination of MRI sequences 33 and 
remnants of large calcium areas are also visible in the en face photos and in the 
histological sections. 
The rigid registration of in vivo and ex vivo MRI is based on the matching of 
a single image slice. A potential registration error of one image slice in this 
procedure would equal the MRI resolution in z-direction, i.e. 0.6 mm. After 
relocation of a half image slice with respect to the original registration, mean 
WSS values varied on average 0.25 Pa. Simulating the mismatch of a complete 
MRI slice resulted in an average deviation in mean WSS of 0.59 Pa. As expec-
ted, larger mismatches resulted in larger WSS deviations. Although a WSS value 
difference of 0.59 Pa appears substantial, deviations in WSS values in the same 
order of magnitude were found to result from variations in vessel segmen-
tations for WSS calculations 34.  As we plan to use this method for assessing 
possible correlations between WSS and histological parameters, the effect 
of possible registration and segmentation inaccuracies on found correlations 
should be carefully documented.
The carotids included in this study are representative geometries, that have a 
stenosis degree of >70%. The nonsignificant change in WSS values after reloca-
tion suggests that the axial gradients in WSS data are not large enough to cause 
significant changes, even in case of mismatch of a complete MRI slice. Plaques 
with relatively irregular lumen outlines will show larger gradients in WSS data. 
In those cases, a registration mismatch is more likely to cause a significant 
change in WSS data on radial bins. In future applications of this pipeline, the 
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‘smoothness’ of the lumen should thus be carefully assessed and, in case of 
irregular plaques, the applicability of this image registration pipeline should be 
re-assessed  
We determined whether a registration mismatch would influence the correla-
tions we want to investigate with the pipeline, namely the identification of a 
possible relation between WSS and a histology parameter. For this purpose, 
we analyzed the correlation between WSS and plaque thickness. In two axial 
locations close to the bifurcation, we found a significant negative correlation 
(p<0.05) between minimum WSS and plaque thickness. The negative correla-
tions remained significant in case of a 0.3 mm mismatch in WSS data. A 0.6 mm 
WSS relocation, resulting in a larger change in WSS, weakened the correlation 
to non-significance in two out of four cases. For all cases, the R value of the 
original registration however, remained negative. Non-significant R values in 
other axial locations in case of original image registration remained non-signi-
ficant. Considering the correlation between mean WSS and plaque thickness, 
the R values after relocation deviated from the R values of the original regis-
tration by 0.045-0.048 on average. Similar to the WSS patterns, the correlation 
between WSS and plaque composition should be reassessed for plaques with a 
highly irregular lumen, potentially requiring additional registration landmarks.
 
In conclusion, our novel MRI-based pipeline can match histology to patient-spe-
cific WSS data. This method can now be used to investigate the relation be-
tween the hemodynamic environment and features of plaque vulnerability. 
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Abstract
Wall shear stress (WSS) is involved in atherosclerotic plaque initiation, yet its 
role in plaque progression remains unclear. We aimed to study 1) the tempo-
ral and spatial changes in WSS over a growing plaque and 2) the correlation 
between WSS and plaque composition, using animal-specific data in an athe-
rosclerotic mouse model. Tapered casts were placed around the right common 
carotid arteries (RCCA) of ApoE-/- mice. At 5, 7 and 9 weeks after cast place-
ment, RCCA geometry was reconstructed using contrast-enhanced micro-CT. 
Lumen narrowing was observed in all mice, indicating the progression of a 
lumen intruding plaque. Next, we determined the flow rate in the RCCA of each 
mouse using Doppler Ultrasound and computed WSS at all time points. Over 
time, as the plaque developed and further intruded into the lumen, absolute 
WSS significantly decreased. Finally at week 9, plaque composition was histolo-
gically characterized. The proximal part of the plaque was small and eccentric, 
exposed to relatively lower WSS. Close to the cast a larger and concentric pla-
que was present, exposed to relatively higher WSS. Lower WSS was significantly 
correlated to the accumulation of macrophages in the eccentric plaque. When 
pooling data of all animals, correlation between WSS and plaque composition 
was weak and no longer statistically significant. In conclusion, our data showed 
that in our mouse model absolute WSS strikingly decreased during disease 
progression, which was significantly correlated to plaque area and macrophage 
content. Besides, our study demonstrates the necessity to analyze individual 
animals and plaques when studying correlations between WSS and plaque 
composition.
Introduction
Wall shear stress (WSS) is the frictional force induced by blood flow acting on 
the endothelial lining of the vessel surface. WSS regulates the inflammatory 
status of the endothelium and thus determines the location of plaque deve-
lopment 1–3. The progression of a plaque is a dynamic process, during which 
vessel geometry undergoes remodeling and narrowing, leading to substantial 
changes in the local WSS environment over time 4–7. As the disease advances, 
plaques grow and they differ in composition, showing either a stable or vulne-
rable phenotype. Vulnerable plaques are characterized by the presence of a 
large necrotic core with a thin overlying fibrous cap and abundant infiltration 
of inflammatory cells 8. Vulnerable plaques are prone to rupture and can cause 
subsequent thromboembolic events 9. A substantial role for WSS in the initiati-
on of atherosclerosis is established, however, whether WSS plays a role in pla-
que growth and/or progression remains under debate. Evidence towards a role 
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for WSS in plaque growth and progression does exist but is ambiguous. Clinical 
studies revealed that in carotid and coronary arteries, plaque rupture was pre-
dominantly located at the upstream shoulder of a plaque 10–13. Plaque composi-
tion was heterogeneous along the direction of blood flow: thinner fibrous caps, 
larger necrotic cores and accumulation of macrophages were observed at the 
upstream shoulder of a plaque, correlating a vulnerable plaque phenotype to 
the location of rupture 12,14–17. Several studies proposed that these regions were 
exposed to increased WSS, suggesting that high WSS may promote plaque 
vulnerability 18–21. 
In contrast, low WSS was correlated to characteristics of plaque vulnerability in 
human and porcine coronary arteries 22–30. Nevertheless, no direct association 
between evolution of WSS and plaque composition was established. We set 
out to study the dynamic process of disease progression and the concomitant 
spatial and temporal changes in lumen geometry and WSS using an atheroscle-
rotic mouse model. In addition, we analyzed the association between WSS and 
plaque composition. 
We use an atherosclerotic animal model in which we can manipulate WSS in 
vivo and induce atherosclerotic plaque development 31–37. We previously sum-
marized the use of surgically manipulated flow models 38 and found that WSS 
distribution was studied only in some of these models and usually not taking 
full 3D vessel geometry into account 34,36,39, while calculation of WSS critically 
depends on detailed vessel geometry and blood flow velocity 40. In a previous 
cross-sectional study, using a tapered cast model 33, Pedrigi et al 37  discovered 
that certain WSS metrics co-localized to the presence of a plaque with increas-
ed Oil Red O-lipid-staining. However, quantitative analysis of plaque compositi-
on was not performed in this study and thus spatial correlations between WSS 
metrics and plaque composition could not be studied. The WSS metrics were 
investigated only at one time point while temporal data were lacking. Due to 
the dynamic nature of plaque progression, monitoring WSS in vivo over time 
is a prerequisite. To the best of our knowledge, no studies have monitored 
temporal and spatial changes of WSS or correlated these to plaque compositi-
on in individual animals. We investigated the evolution of geometry, flow and 
WSS during plaque progression and the correlation between WSS and plaque 
composition in individual animals by analyzing WSS in vivo at various time 
points during plaque progression. First, we obtained mouse-specific geometri-
cal and flow data to compute WSS distribution at 5, 7 and 9 weeks after cast 
placement. This enabled us to monitor changes in WSS over the very same 
plaque during its growth and progression into an advanced plaque. At 9 weeks 
after cast placement, vessel samples were harvested and plaque composition 
was histologically characterized. Finally, regression analysis was performed to 
determine correlations between plaque composition and WSS. 
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Methods
Animals and cast placement
Female ApoE-/- mice on C57BL/6J background (n = 9) were purchased from 
Charles River (Maastricht, The Netherlands). At 13 weeks of age, normal chow 
diet was replaced with an atherogenic Western diet and provided ad libitum 
(Arie Blok, The Netherlands). Cast surgery was performed two weeks later on 
the animals under isoflurane-induced anesthesia as described previously 33,41,42. 
The average weight of the mice was 21.9 grams. A tapering cast was placed 
around the right common carotid artery (RCCA), leading to changes in local 
WSS environment and subsequent plaque development. All animal experi-
ments were performed conform to the guidelines from Directive 2010/63/EU 
of the European Parliament on the protection of animals used for scientific 
purposes and approved by ethical committee of Erasmus MC Rotterdam.
Contrast-enhanced micro-CT imaging and RCCA lumen reconstruction
To compute WSS in RCCA, we used time point and mouse-specific vessel 
geometries as the input, which was captured by contrast-enhanced micro-CT 
imaging (Quantum FX) with isotropic resolution of 40 µm. Images in Hounsfield 
unit (HU) were reconstructed. RCCA geometry of each animal at week 5, 7 and 
9 was analyzed using in-house developed modules in MeVisLab (MeVisLab 
2.2.1) and Matlab (Matlab 2012). The segmentation protocol was previously 
established 40. RCCA lumen surface was reconstructed from its origin at the 
bifurcation of the brachiocephalic artery, to its bifurcation into the internal and 
external carotid artery. Mice were anesthetized with isoflurane with scanning 
parameters of 90kvp, 160µA, field of view 20mm (Fig 1). The radiation dose 
of each micro-CT scan was approximately 1.7 Gy. Mice underwent 3 scans in 
total, with 2 week time intervals.  To determine a possible effect of radiation 
on atherosclerosis progression, we included a control group (n = 5) that was 
not imaged and analyzed plaque composition 9 weeks after cast placement. 
No significant differences in plaque area or macrophage content were found 
(data not shown). Contrast agent eXIA 160 was used with an injection dose of 
150 µl/25 grams of body weight. One mouse had paralyzed hind limbs after 
the 1st imaging and was euthanized. One mouse was found dead before the 3rd 
imaging at week 9. These two mice were excluded from subsequent analyses. . 
Note that micro-CT is unable to capture outward remodeling of the vessel wall 
but allows visualization of lumen surface. 
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Figure 1: Experimental scheme. At t = -2 weeks, ApoE-/- mice were fed a high fat 
diet; Cast operation was performed on the right common carotid artery (RCCA) at t=0 
week to induce plaque growth (Note that at t = 0, mice were 15 weeks of age); At t = 
5, 7, 9 weeks during plaque progression, 3D RCCA vessel geometry was reconstructed 
using contrast-enhanced micro-CT imaging. Blood flow velocity through the RCCA was 
measured by Doppler Ultrasound; Both micro-CT and ultrasound were carried out in 
each individual mouse; 3D WSS maps at 3 time points of the same animal were thus 
generated using these imaging data; After the last imaging moment at t = 9 weeks, 
animals were euthanized, RCCA was excised  for histological analyses.
Doppler Ultrasound imaging
Ultrasound imaging was performed using Vevo 2100 (VisualSonics) with a 
40-MHz transducer. Blood velocity wave form was measured upstream of the 
RCCA under pulse-wave mode at 5 different time points: before and imme-
diately after cast surgery, at 5, 7 and 9 weeks after cast surgery (Fig 1). RCCA 
diameter was measured under M-mode at the same location of the pulse-wa-
ve measurement, thus allowing conversion of blood velocity (mm/s) to flow 
(mm3/s) assuming a parabolic velocity profile.
Mesh and CFD simulations
RCCA lumen surface was smoothed using Vascular Modelling Tool Kit (VMTK 
1.2). The superfluous ends at the proximal and distal side of the vessel surfa-
ce were clipped and flow extensions were added. A volume mesh with prism 
layers was then generated using ICEM (ICEM-CFD 14.5, Ansys). Parameters 
including number of mesh elements, maximum element size, use of curvatu-
re/proximity based refinement, numbers and thickness of prism layers were 
optimized to obtain a mesh-independent solution resulting in approximately 
640,000 elements. Surface area of the RCCA inlet was derived, enabling the 
calculation of location-specific blood flow velocity as boundary condition.
Several assumptions were made when solving the Navier-Stokes equations. 
First, the endothelial cells are exposed to time varying WSS levels. It is well 
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established that the response of these cells is triggered by the time-averaged 
WSS that they are exposed to 43. To obtain the time-averaged WSS, we can use 
steady flow simulations, using the average flow through the vessel as input 44. 
In previous studies, it was demonstrated that other time dependent WSS deri-
ved parameters such as Oscillatory Shear Index (OSI) are not relevant due the 
geometry and flow conditions in this model 37,40, unlike in other vascular terri-
tories 45,46. Furthermore, we assumed the WSS values are not influenced by the 
distensibility of the vessel wall. For blood flow in carotid arteries in mice, it was 
previously shown that distensibility is only important in the carotid bifurcation, 
and has a negligible effect in the common carotid artery 47. Finally, blood was 
modeled as a Newtonian fluid, a valid assumption given the high shear rates in 
the carotid arteries of mice 48. Therefore, we confined ourselves to steady flow 
simulation. 
The resulting Navier-Stokes equations were solved by computational fluid 
dynamics (CFD) using Fluent (Fluent 14.5, Ansys). Blood was modeled to be 
incompressible. A constant viscosity of 3.5 × 10-3 kg/m/s and a density of 1060 
kg/m3 were used 47,49. Vessel wall was assumed to be rigid. A parabolic velocity 
profile was imposed as inlet boundary condition. Average blood flow veloci-
ty of the RCCA was derived from Doppler velocity measurements. For outlet 
boundary condition, zero pressure was used. WSS was then derived from the 
computed velocity field. Finally, post-processing and analysis were performed 
using CFD-Post (CFD-Post 14.5, Ansys) and Matlab. 
Histological staining and analysis
After final imaging at week 9 (Fig. 1), mice were euthanized by isoflurane 
overdose. The vascular system was then flushed with PBS through the left 
ventricle. Subsequently, 4% paraformaldehyde (PFA) in 0.15 mM PBS was used 
for pressure fixation at 100 mmHg 50. Tissue around the RCCA was carefully 
cleaned, exposing the vasculature. The RCCA, cast, proximal brachiocephalic 
bifurcation and aortic arch could be clearly seen (Fig. 2B). Photos of RCCA were 
taken with a 1 mm grid strip. The cast was then carefully removed from the 
vessel. Proximally, the RCCA was excised 3 mm distal to the aortic arch and 
distally after the carotid bifurcation. RCCA was then immersed in 4% PFA for 
24h at room temperature. Tissue samples were then processed and embed-
ded in paraffin for histological analysis. We focused on the plaque upstream 
of the cast because its composition was relevant to our aim of study. We did 
not investigate the region within the cast because this region was exposed to 
increased WSS, and thus no plaque formation was observed. For the region 
downstream of the constriction, the cast was generally located close to the 
bifurcation. We can therefore expect a strong interplay between the presence 
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of the jet downstream of the cast and the flow features associated with the 
division of the flow in the carotid bifurcation. These features will be greatly 
influenced by the flow division over the internal and external carotid artery. 
This ratio will change during the progression of the disease 47. Since we did not 
measure flow in the internal or external carotid artery due to restricted time 
allocated for flow measurements, we cannot establish flow division and thus 
cannot evaluate WSS patterns downstream of the cast reliably. Therefore, we 
decided to exclude the plaque formed downstream in our analysis. Serial secti-
ons of the plaque upstream to the cast were collected. On average each plaque 
contains 21 serial sections (5 µm, at 50 µm interval), the two sections adjacent 
to the cast were excluded from the analysis to avoid possible confounding 
effects from the presence of the cast. Sections were stained for general plaque 
morphology (H&E), macrophages (CD68, Bio-Rad), endothelium (CD31, Diano-
va), and collagen (Resorcin-Fuchsine). Atherosclerotic plaque area, media area, 
and relative macrophage area were quantified (BioPix iQ3.2). Necrotic core was 
defined as a-cellular, a-nuclear areas, free of H&E staining 51.
Figure 2: Spatial matching of histological sections to 3D WSS map of an individual 
RCCA. (A)  Representative H&E stained sections of the RCCA proximal to the cast, 
showing the healthy part, eccentric plaque part and the concentric plaque part. (B) 
Overview of the RCCA in situ before excision with 1 mm-spacing grid paper (Arrowhead: 
black suture around the cast; Arrow: proximal side of the plaque; Asterisk: plaques 
located at the inner curve of the aortic arch and brachiocephalic artery). (C) 3D WSS 
map.
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Registration of histological staining to 3D WSS maps
For each animal, histological sections of the RCCA (Fig. 2A) were spatially 
registered to 3D WSS maps at various time points (Fig. 2C) via the in vivo RCCA 
overview (Fig. 2B). We correlated plaque composition to WSS at different time 
points because although the effect of WSS on the endothelium is instant, the 
subsequent changes in plaque composition are not. Thus it is necessary to 
register WSS maps at week 5, 7, and 9 to plaque composition observed at the 
latest time point. To do the registration, we calculated RCCA vessel shrinkage 
from the in vivo situation to histology. Two landmarks are needed for this 
purpose. Since vessel segments with and without plaques were likely to exhibit 
different elasticity and therefore shrinkage, selection of landmarks should pre-
ferably be the beginning and the end of a plaque. The proximal edge of the pla-
que was clearly visible both on the RCCA overview (Fig. 2B, arrow) and histo-
logical sections (Fig. 2A, 2nd section on the left). We thus selected it as the first 
landmark. The end of the plaque coincided with the proximal edge of the cast, 
which can be identified on histology. However, due to the scar tissue surroun-
ding the cast, the distal edge of the plaque was not clearly visible on the RCCA 
overview. The black suture around the cast, however, can be easily spotted (Fig. 
2B, arrowhead). Since the distance to the proximal edge of the cast was known 
(0.5 mm), we could pinpoint it as our second landmark. The average longitudi-
nal shrinkage was 51%±20%, comparable to that reported previously 37. On the 
3D WSS maps, location of the cast was identified from the micro-CT images. 
Using the individual shrinkage factor obtained for each mouse, histological 
sections were then spatially registered to the 3D WSS maps at week 5, 7 and 
9 (Fig. 2C). We investigated the association between plaque composition and 
WSS profiles at 3 time points as the duration between changes in WSS and the 
actual effect of that particular WSS on plaques composition is unknown.
According to the histological sections, proximal RCCA was divided into 2 seg-
ments: the healthy segment and the diseased segment. The corresponding seg-
ments were also identified on the 3D RCCA geometry reconstructed from the 
micro-CT images at week 9. Since histology was only available at week 9 and 
micro-CT imaging can only capture lumen geometry but not plaque compositi-
on, it was not possible to pinpoint the border between the healthy and di-
seased segment on the 3D RCCA geometry at week 5 and 7. We used the histo-
logy data obtained at week 9 to identify the healthy and diseased segments for 
these two time points. Lumen area in the proximal RCCA was derived from the 
3D RCCA geometry assuming circular cross-section 52. Degree of stenosis was 
calculated as the percentage ratio between the minimum lumen area in the 
diseased segment and the average lumen area of the healthy segment. When 
analyzing histological data, the diseased segment was further divided into two 
segments. Proximally, the plaque was composed of sections with eccentric pla-
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que growth, in which plaque did not cover the entire circumferential direction. 
Close to the cast, the plaque covered the entire circumferential direction and 
was thus concentric (Fig. 2A).
Statistics
Data are presented as mean ± SD and analyzed in Matlab and RStudio. Diffe-
rences between samples were evaluated using a paired, two-tailed, Student’s 
t-test or repeated measures ANOVA. A Tukey’s honestly significant difference 
(HSD) post-hoc test was performed after the ANOVA test. Correlations between 
histological quantifications and WSS data were performed by linear regression. 
A value of p<0.05 was considered significant.
Results
In vivo micro-CT reveals various plaque progression profiles among 
animals
3D RCCA vessel geometries were reconstructed from contrast-enhanced mi-
cro-CT at 5, 7 and 9 weeks after cast placement. Various plaque progression 
profiles were evident among animals. Changes in lumen diameter were most 
evident between either 7 and 9 weeks, or 5 and 7 weeks. In a representative 
animal (mouse number 1 shown in Fig 3-6), lumen narrowing was obser-
ved gradually over time (Fig. 3A, pink line, 3B). Degree of stenosis increased 
steadily from 55% at week 5 to 63% at week 7 and 80.0% at week 9 (Fig. 3A, 
pink line). 
In all animals (n = 7), at week 5, lumen narrowing can be clearly seen in the 
diseased segment upstream of the cast (Suppl. Fig. 1), suggesting presence of 
a lumen intruding plaque. Degree of stenosis averaged among 7 animals was 
41±11% at week 5, 57±8% at week 7 (p<0.05 vs. week 5) and 62±16% at week 9 
(p<0.05 vs. week 5) (Fig. 3A, black line). 
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Figure 3: (A) Degree of stenosis of RCCA at 5, 7 and 9 weeks after cast placement: 
Average of 7 animals (black line, *p<0.05, repeated measures ANOVA); Mouse 1 (pink 
line); Shadow area indicates data range of 7 animals. Notably, animals exhibited various 
plaque progression profiles. (B) 3D reconstruction of RCCA at 5, 7 and 9 weeks after cast 
placement of Mouse 1. Direction of blood flow is indicated by the arrow in the upper left 
corner. Location of the cast is illustrated. Upstream to the cast, the RCCA is divided into 
a healthy segment and a diseased segment based on the week 9 histology data. Lumen 
narrowing can be observed over time, suggesting the development and progression of a 
lumen intruding plaque.
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Blood flow in RCCA decreased over time
Blood velocity was measured upstream of the RCCA before and immediately 
after cast surgery, and at 5, 7 and 9 weeks after cast placement. Blood flow in 
the RCCA was then converted using the measured parameters. In our repre-
sentative animal, blood flow reduced from 47.3 mm3/s to 19.4 mm3/s after 
cast placement and furthered decreased during plaque progression, from 14.8 
mm3/s at week 5 to 11.4 mm3/s at week 7 and 2.0 mm3/s at week 9 (Fig. 4, pink 
line).
All mice except for one (Mouse number 3 in Suppl. Fig. 1) showed a general 
decrease in blood flow over time. Blood flow in the RCCA averaged from all 7 
animals decreased immediately after cast placement from 38.4±9.0 mm3/s to 
28.0±5.5 mm3/s (Fig 4, black line). At week 5 and 7, blood flow further reduced 
to 19.8±9.2 mm3/s and 16.4±6.0 mm3/s (p<0.05 vs. before cast placement). Fi-
nally, at 9 weeks, blood flow was 9.9±11.3 mm3/s, significantly lower than that 
before and after cast placement (p<0.05). 
Figure 4: Blood flow along RCCA over time: Average of 7 animals showed a general 
decrease in blood flow over time (black line, * indicates p<0.05, repeated measures 
ANOVA); Mouse 1 (pink line); Shadow area indicates data range of all animals.
WSS profiles as determined by animal-specific geometry and flow data
The spatial and temporal 3D WSS distribution based on the mouse-specific 
geometry and flow data was computed at 5, 7 and 9 weeks after cast place-
ment with CFD. Fig. 5 illustrates the evolution of the 3D WSS distribution of 
our representative animal. Before cast placement, average WSS was 14.4±9.4 
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Pa decreasing to 12.9±4.4 Pa after cast placement. At week 5, WSS was low 
upstream of the cast with an average value of 4.1±2.2 Pa (Fig. 5A, upper panel). 
At week 7 and 9, as blood flow in the RCCA gradually reduced, WSS decreased 
in the RCCA (Fig. 5A, middle and lower panel). WSS distribution in the RCCA up-
stream to the cast was further analyzed in the healthy and diseased segment. 
At week 5, the two segments were exposed to WSS of 2.2±0.1 Pa and 5.0±2.2 
Pa respectively (Fig. 5C, green bars). Furthermore, WSS distribution was hetero-
geneous over the diseased segment (Fig. 5B, green line). Over time, as lumen 
area remained constant along the healthy segment, the decrease in blood flow 
lead to lower WSS in this region (Fig 5B, blue and red lines), with 1.3±0.1 Pa at 
week 7 and 0.3±0.0 Pa at week 9 (p<0.05, Fig. 5C, blue bars). For the diseased 
segment, the lumen area narrowed gradually over time. Combined with the 
reduction in blood flow over time, WSS in this segment decreased significantly 
to 3.4±1.7 Pa at week 7 and 1.7±1.0 Pa at week 9 (p<0.05, Fig. 5C, red bars). 
Since various geometry features and blood flow patterns were observed among 
the 7 mice, different WSS profiles were evident, presented in Suppl. Fig. 1. A 
general reduction in WSS over time was seen in 5 animals. Mouse number 2 
showed an increase in WSS from 5 to 7 weeks, with a subsequent dramatic 
decrease from 7 to 9 weeks. Mouse number 3 was the only one showing a 
WSS increase over time, while in all other mice WSS was minimal in both the 
healthy and diseased segment at week 9. Furthermore, in all mice, the healthy 
segment was exposed to significantly lower levels of WSS when compared to 
the diseased segment at all time points. 
Plaque morphology and composition varied within a single plaque
Histological analysis revealed the presence of one continuous plaque in the 
RCCA upstream to the cast 9 weeks after cast placement. However, differences 
in morphology and composition were found within this continuous plaque de-
pending on the axial location. Histological sections of our representative animal 
are shown in Fig. 6. A smaller and eccentric plaque was observed proximally 
(Fig. 6, left section). Closer to the cast, the plaque was concentric and larger 
(Fig. 6, right section). Plaque area of the eccentric part was 0.04 mm2 compa-
red to that of the concentric plaque 0.15 mm2. Relative macrophage area in the 
eccentric plaque was 24.6%, while in the concentric plaque a relative macrop-
hage area of 13.9% was observed. In the eccentric plaque, relative necrotic 
core area was 2.7%, while it was 15.0% in the concentric plaque (data not 
shown).
The eccentric-concentric plaque morphology was present in all animals. Plaque 
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area was significantly smaller in the eccentric plaque compared to that of 
the concentric plaque (0.03±0.01 mm2 vs. 0.12±0.02 mm2, p<0.05) (Fig. 6A). 
Macrophages were more concentrated in the eccentric plaque compared to 
that of the concentric plaque (Fig. 6B). On average, relative macrophage area in 
the eccentric plaque was 28.3±6.9%, while in the concentric plaque a relative 
macrophage area of 13.4±3.5% was observed (p<0.05). In the eccentric plaque, 
relative necrotic core area appears to be somewhat smaller than that of the 
concentric plaque (Fig 6C, 15.2±8.2% vs. 21.1±7.7%). However, the difference 
between the eccentric and concentric plaque regarding relative necrotic core 
area was not statistically significant.
Correlation between WSS and plaque composition
Plaque area, macrophage content, and necrotic core area at week 9 was linked 
to WSS profiles at week 5, 7 and 9 (Fig. 7). In our representative animal, pla-
que area was positively associated with WSS and significant at all time points 
(p<0.05). Accumulation of macrophages was negatively correlated to WSS and 
significant at both week 5 and 7 (p<0.05), indicating that lower WSS suggested 
a pro-inflammatory profile in plaques. A positive correlation between relative 
necrotic core area and WSS level was positive at all 3 time points, however only 
significant at week 5 and 7. Fig. 7 summarizes the correlation between WSS 
and plaque area, macrophage content, and necrotic core area of all 7 animals 
at 3 time points. Thus for each plaque parameter, there were 7x3=21 observa-
tions. In 6 out of 7 animals at all time points, a positive and statistically signifi-
cant correlation between WSS and plaque area was seen in 17 out of 21 obser-
vations. Inverse correlation between WSS and macrophages was observed in 
6 out of 7 animals where 12/21 observations were statistically significant, and 
6/21 showed a non-significant negative correlation. The correlations between 
WSS and relative necrotic core size showed less significance. For relative necro-
tic core size, 6/21 correlations were positive and statistically significant. 
The correlation between plaque composition and WSS profiles were analyzed 
in each individual animal. When histological data from all the animals was 
pooled together, as is usually the followed approach in these types of studies, 
a positive but very weak correlation between WSS and plaque area was seen, 
which was not statistically significant at any time point (the correlation coeffi-
cient at week 5 was 0.08, 0.1 at week 7 and 0.04 at week 9, p>0.05), contrary 
to the result obtained from the individual animal analysis. Pooling data results 
in different and not necessarily correct correlation patterns.
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Figure 5: Illustration and quantification of WSS in a RCCA. (A) 3D WSS distribution 
in the RCCA of representative mouse 1 at 5, 7 and 9 weeks after cast placement. 
Circumferentially-averaged WSS along the RCCA is shown (B). Proximally the RCCA was 
divided into a healthy and diseased segment, indicated by the vertical dashed line, based 
on the week 9 histology data. WSS distribution was heterogeneous over the diseased 
segment. Averaged WSS in both segments significantly decreased over time and was 
relatively higher in the diseased segment (Student’s t-test, *p<0.05).
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Figure 6: Characterization of plaque composition. Representative histological staining 
of the eccentric and concentric segment of representative mouse 1 and quantification of 
all mice is shown. (A) Plaque area (mm2) was delineated by CD31 endothelial staining; 
(B) Relative macrophage area (%) was determined using CD68 staining; (C) relative 
necrotic core area (%) was delineated by H&E nuclei staining (Arrows: necrotic cores); 
Plaque area was significantly larger in the concentric segment, while macrophage area 
was larger in the eccentric segment (Student's t-test, n = 7, *p<0.05). Bar is 100 µm.
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Figure 7: Correlation between WSS at all time points and plaque composition. Yellow: 
positive correlation, p<0.05; Blue: positive correlation, p>0.05; Light Yellow: negative 
correlation, p<0.05; Light Blue: negative correlation, p>0.05. 
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Discussion
Our study described the temporal and spatial changes in vessel geometry, 
blood flow and concomitant WSS over an advanced murine plaque and its cor-
relation to plaque area and macrophage content. First, we demonstrated that it 
was possible to follow changes in lumen area over time using contrast-enhan-
ced micro-CT. Lumen narrowing was observed in all animals upstream to the 
cast, implying the formation of a lumen intruding plaque. The minimum degree 
of stenosis varied among animals at each time point, leading to different pro-
gression profiles over time. These differences in disease progression rate were 
not related to the initial degree of stenosis at week 5 or plaque size observed 
at week 9. Immediately after cast placement, flow reduction of 23.3±19.8% was 
observed in the RCCA, comparable with previously reported values 33,37. During 
plaque progression, as stenotic degree increased over time, blood flow in the 
RCCA decreased gradually from week 5 to 9. Flow decrease was also observed 
in animals with constant degree of stenosis over time. Therefore, the observed 
flow decrease was not only due to the increasing stenotic degree of the lumen 
intruding plaque, but also likely to be due to increasing resistance of the distal 
vascular bed beyond the carotid bifurcation. In general, blood flow decreased 
during plaque progression in all mice, except one. Our results strongly sugge-
sted that there were temporal and animal-specific variations in vessel geom-
etry and blood flow and therefore one should not use generic values when 
computing WSS distribution as suggested previously 53. 
Variations in the local geometrical and blood flow data at the time of investiga-
tion lead to a complex spatial and temporal distribution of WSS in vivo among 
animals. As blood flow reduced and vessel diameter remained constant, RCCA 
was exposed to dramatically decreasing levels of absolute WSS over time. Ho-
wever, over all, WSS decreased over time and was minimal at week 9 in all ani-
mals but one. Generally it is believed that WSS over a lumen intruding plaque 
would increase over time due to the increased degree of stenosis. Our findings 
showed that this is not the case in this animal model, contrary to the general 
consensus 54. Nevertheless, if we look at the spatial distribution of WSS in the 
upstream RCCA, relative WSS showed a gradual increase from the healthy 
segment to the eccentric and then concentric plaque segment, which is in line 
with the general consensus. Although relative WSS distribution followed the 
expected spatial pattern, one should keep in mind that it was on a background 
with dramatically decreased absolute WSS levels. This implies that previous 
studies which correlated high WSS to plaque pathogenesis using this mouse 
model should potentially be reinterpreted. This underlines again the importan-
ce of computing WSS on subject-specific flow and geometries.  
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To analyze correlations between WSS and plaque components, we analyzed 
plaque composition after the final imaging moment. To visualize the spatial 
heterogeneity of plaque composition, we performed consistent sampling of 
the plaque, similar to the study reported before 55. This analysis revealed the 
presence of one continuous plaque. Its composition varied in the axial directi-
on (Fig. 8). In all animals, proximally, the plaque was small and eccentric, and 
abundant in macrophages. The macrophage concentration was comparable to 
that reported by Cheng et al 33. We observed that the plaque segment located 
closer to the cast was big and concentric. CT data demonstrated that vessel 
lumen narrowing was first observed close to the upstream part of the cast, sug-
gesting that the plaque revealed here was present for a longer time and thus 
its composition was more advanced, while the proximal part of the plaque is 
“younger” and less advanced. The spatial heterogeneity of the plaque implied 
that sampling location should be taken into account when analyzing plaque 
composition in any animal model for atherosclerosis or human atherosclerotic 
sample15. Results might be different if one only selects histological sections 
from either eccentric or concentric diseased segments. 
Figure 8: Schematic overview plaque morphology. Proximally, the plaque was smaller 
and eccentric with abundant accumulation of macrophages. Closer to the cast, the 
plaque was larger and concentric.
80 Chapter 4
Using mouse-specific absolute WSS at a given time point and using the histo-
logical data, we demonstrated a strong inverse relationship between macrop-
hages and WSS. Macrophages accumulated in the proximal eccentric plaques 
where WSS was lowest, confirming the pro-inflammatory effect of low WSS 
reported before 1,14,56. In this mouse model, the continuous exposure to redu-
cing levels of WSS in the proximal eccentric plaque correlated to inflammation 
and thus plaque growth. However, regardless of the homogeneous distribution 
of WSS in the upstream RCCA, the proximal segment of the plaque had an ec-
centric composition. In addition, although the upstream part of the RCCA was 
homogeneously exposed to extremely low WSS, plaque was only present close 
to the cast. These evidences suggested that low WSS alone is not incentive 
enough to induce plaque initiation. We think that the plaque initially grew from 
the region close to the cast, and there might be factors (damage from the cast 
surgery, distribution of inflammatory cells or layout of fibrotic tissues) from 
the existing plaque that induced a non-homogeneous growth pattern in the 
proximal direction. In addition, we showed that 6 out of 7 mice had a positive 
and significant correlation between WSS and plaque area. The one animal that 
showed contrasting correlations (mouse number 6 in Fig. 7) presented with 
such extensive plaque progression that the stenosis created by the plaque was 
more severe than the stenosis induced by cast placement (Suppl. Fig. 1).  
In our study, we observed large variations in both WSS distribution and plaque 
composition among animals. Correlation between WSS distribution and plaque 
composition reduced when data were pooled. This implies that one can miss 
out on important correlations if the often-applied approach of pooling WSS and 
histological data is used. Similarly, De Wilde 7 showed that pooling data lead to 
misinterpretation of correlation between WSS metrics and plaque composition. 
Therefore, when analyzing functional parameters from one to another, using 
subject-specific WSS and histological data is necessary. 
Study Limitations
A limitation of this study was that we were not able to perform rotational mat-
ching between the 3D WSS maps to the lumen surface obtained from histology. 
Subdividing the 3D WSS maps into cross-sections and matching it to the cor-
responding orientation of the histological sections would potentially increase 
information density. In our study, the upstream RCCA was relatively a straight 
segment where WSS distributed homogeneously along the lumen circumferen-
ce. We thus expected little effect of performing rotational matching. In addi-
tion, we focused on computing WSS and did not compute wall stress which is 
expected to play a role, especially close to the cast 42, which is why we did not 
include the sections close to the cast in our histological analysis. A limitation of 
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our model is that mice do not present with vulnerable plaques in accordance 
with the definition of a human vulnerable plaque and that is mouse plaques 
are not rupture-prone 42. The differences between mice –and animal models in 
general- and humans were reviewed by us and others 42,57,58. The implication of 
these differences is that translation of the findings based on these animal data 
to patient studies should therefore be done cautiously. A relevant example of 
the difference between mice and humans pertains to cap thickness, a strong 
indicator of plaque vulnerability in human plaques, which is ill-defined in mice 
due to the presence of multiple necrotic cores, located deep in the plaque. We 
therefore decided not to put forward cap thickness analyses in this manuscript.
Conclusion
We quantified the temporal and spatial evolution of WSS in an atherosclerotic 
mouse model and we studied the correlation between the animal-specific WSS 
data and plaque composition in the same animal. Strikingly, due to the tem-
poral changes in geometry and flow, WSS decreased over time during disease 
progression, contrary to the general belief. In the majority of the mice, lower 
WSS was associated with elevated levels of inflammation, which mainly loca-
lized proximally where the plaque was small and eccentric. Closer to the cast 
where a larger concentric plaque was observed, higher WSS was associated 
with increased plaque area. In addition, our study clearly demonstrated the 
necessity to analyze individual animals and plaques when studying correlations 
between WSS and plaque composition.
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Supplemental Figure 1: WSS distribution in all mice. 3D WSS distribution in the RCCAs at 
5, 7 and 9 weeks after cast placement. Circumferentially-averaged WSS along the RCCA 
is shown. Each color bar shows animal-specific absolute WSS levels.
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Abstract
Atherosclerosis is a lipid and inflammation-driven disease of the arteries that 
is characterized by gradual buildup of plaques in the vascular wall. A so-called 
‘vulnerable plaque’, consisting of a lipid-rich necrotic core contained by a thin 
fibrous cap, may rupture and trigger thrombus formation, which can lead to 
ischemia in the heart (heart attack) or in the brain (stroke). In this study, we 
present a protocol to investigate the lipid composition of advanced human 
carotid plaques using matrix-assisted laser desorption ionization (MALDI) mass 
spectrometry imaging (MSI), providing a framework that should enable the 
discrimination of vulnerable from stable plaques based on lipid composition. 
We optimized the tissue preparation and imaging methods by systematically 
analyzing data from three specimens: two human carotid endarterectomy sam-
ples (advanced plaque) and one autopsy sample (early stage plaque). We show 
a robust data reduction method and evaluate the variability of the endarterec-
tomy samples. We found diacylglycerols to be more abundant in a thrombotic 
area compared to other plaque areas and could distinguish advanced plaque 
from early stage plaque based on cholesteryl ester composition. We plan to use 
this systematic approach to analyze a larger dataset of carotid atherosclerotic 
plaques.
Introduction
Atherosclerosis is the cause of more than 10 million deaths worldwide, and a 
major contributor to long-term morbidity and disability 1. This disease of the 
artery walls is characterized by the gradual formation of depositions in the 
vascular wall that are called atherosclerotic plaques. Plaque growth is initia-
ted by endothelial dysfunction and driven by impaired lipid transport mecha-
nisms, which trigger an inflammatory response. Lipids thus play a key role in 
the pathogenesis of atherosclerosis. Besides a variety of lipid species, these 
plaques contain calcifications, fibrous tissue, smooth muscle cells and necrotic 
material 2,3. Depending on the tissue composition and structure of the plaque, 
plaques can be either ‘stable’ or ‘vulnerable’, the latter means they are prone 
to rupture. Plaque rupture may trigger embolization of fragments of plaque 
tissue in the bloodstream, which, depending on the anatomical location of the 
plaque, can lead to stroke or myocardial infarction 4,5. The mechanisms driving 
the evolution of a stable plaque to a vulnerable phenotype are not known in 
detail, although it is clear that defective or unbalanced lipid transport plays a 
key role 6-10. The recent LRP study (presented at TCT2018 11) demonstrated that 
coronary vessel segments with lipid-rich plaque have a >4 times higher clinical 
event rate than vessel segments without such plaque, highlighting the impor-
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tance of plaque lipid content for triggering ischemia. We aim to study whether 
the lipid profile differs between stable and vulnerable plaque types. To deter-
mine whether a plaque’s lipid profile can be correlated to plaque phenotype 
and, therefore, risk of rupture, variation between and within plaque samples 
needs to be assessed. In this study we present a mass spectrometry imaging 
(MSI) method for systematically studying plaque lipid distribution at various 
stages of development.  MSI is an emerging experimental technique in the mo-
lecular characterization of biological samples. Using MSI, the molecular compo-
sition of thin tissue sections can be imaged at a micron-scale resolution. As an 
initial step, MSI requires ionization of the tissue section. Different methods of 
ionization exist, including matrix-assisted laser desorption ionization (MALDI), 
a commonly used ionization method for biological samples 12. The main ad-
vantages of MALDI are its ability to generate singly charged ions, which greatly 
simplifies analysis of mass spectra, and its ability of so-called ‘soft’ ionization, 
preventing molecules from fragmenting during the ionization process 12. MAL-
DI-MSI is suitable for the detection of small molecules, such as lipids. 
To date, few studies of (MALDI-)MSI on human arteries have been published 
13-19.They explored the parameter space of atherosclerotic plaque composition 
as sampled by MSI along various dimensions. Prior work examined different 
arterial beds, i.e. aorta 17, carotid 15,16,18, coronary arteries 14, femoral or popli-
teal  13,19, and in the ionization method used, i.e. MALDI 13,17-19, secondary ion 
mass spectrometry (SIMS) 14,15 or desorption electrospray ionization (DESI) 16. 
Clinically relevant plaques, those that are likely to precipitate ischemic events, 
contain a variable mix of lipids 7. In studying the role of various lipids 8,20 in the 
atherosclerotic disease process, it is therefore important to optimize the analy-
sis for accurately sampling the lipid spectrum, and to quantitatively understand 
the variance in measured ion abundances. We consequently chose to focus on 
lipid-rich plaques only, and moreover restricted ourselves to carotid plaques, as 
these are a major precursor of ischemic stroke 21.
Our aim is to develop a MALDI-MSI pipeline for the analysis of lipids in hu-
man carotid artery plaques, suitable for assessing the variation in lipid profile, 
both between different plaque specimens and within different locations in the 
same specimen. To that aim, we add the following insights to the existing MSI 
knowledge: (1) We describe how arterial tissue should be processed, such that 
the combination of MALDI-MSI and histological information enables contextu-
alization of MSI data in terms of the known morphological features of plaque 
pathology. (2) We combine various MSI data analysis methods into a robust 
data processing pipeline that reliably reduces an MSI dataset into manageable 
lipid-specific results. We describe this pipeline in detail to encourage other 
researchers to follow similar pipelines in their own research. (3) We assess the 
reproducibility of measurements by calculating the coefficient of variation of 
MALDI-MSI measurement results of tissue sections that were located close 
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together.
In addition, we discuss tentative observations in three human carotid plaques 
that illustrate the potential for imaging lipid biochemistry in atherosclerosis. 
This method is readily applicable to larger collections, limited by scan time, of 
carotid plaque specimens, allowing to assess the relation between the carotid 
plaque’s molecular lipid composition and plaque type using statistical methods.
Methods
Materials
DPBS (without Calcium and Magnesium), KP Haematoxyline mayer 
(VWRK4085-9002), Resorcin (1075930100), SuperFrostPlus glass slides (76 
× 26mm) were purchased from VWR (The Netherlands). Eosine (HT110232-
1L), Oil Red O (00625-25G), Basic Fuchsin (857343-25G), Ferric(III) Chloride 
(157740-100G), 2,5-dihydroxybenzoic acid (98%, 149357-100G) and porcine 
type A gelatin were purchased from Sigma-Aldrich (The Netherlands). HPLC 
grade acetone was purchased from Fisher Scientific (The Netherlands). Mouse 
anti-human CD31 (JC/70A, ab9498) and, mouse anti-human CD68 (KP1, 
ab955) were purchased from Abcam (United Kingdom). EnVision+Kit (HRP, 
mouse, 1100 tests, 110 ml, K4001) was purchased from Agilent (the Nether-
lands). Lipid standards Cholest-5-en-3ß-yl heptadecanoate (CE 17:0) 1mg/mL 
(700186M-1mg) and 1,2-diheptadecanoyl-sn-glycero-3-phosphocholine (PC 
17:0) 10 mg/mL (850360C-25mg) were purchased from Avanti Polar Lipids 
(USA).
Tissue collection
Carotid endarterectomy (CEA) surgery was performed by carefully opening the 
outer wall of the carotid artery and excising the plaque by separating the inti-
ma and media. This protocol preserves an intact lumen and plaque morphology 
22 . Two human carotid plaque specimens, harvested at carotid endarterectomy 
(CEA) surgery, were rinsed in phosphate-buffered saline (DPBS), snap frozen 
and stored at -80°C until further processing. A third carotid artery specimen, 
without apparent atherosclerotic disease, was collected at autopsy within 24 
hours postmortem, from a subject with a non-cardiovascular cause of death. 
This specimen was rinsed in DPBS and stored in the same manner. Tissue col-
lection was performed according to protocols sanctioned by the Ethics Board at 
Erasmus MC (MEC 2008-147 for carotid endarterectomy samples, MEC 2017-
300 for the autopsy sample).
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Sample preparation
One CEA specimen, referred to as P1, was transversally divided into 1 mm 
segments to study intraplaque variability. We hypothesize that the plaque’s 
molecular lipid composition may change along the length of the vessel. Five 1 
mm segments, originating ≈3mm apart, evenly spaced along the axial length of 
the CEA sample, were used for imaging. Three of the segments were located 
caudal to the carotid bifurcation and two segments originated from the internal 
carotid artery, see Fig. 1. The second CEA specimen, referred to as P2, and the 
autopsy specimen, referred to as A, were imaged in a single axial location. The 
imaged 1 mm segment of P2 was located cranial to the bifurcation, in the in-
ternal carotid artery, where atherosclerotic disease stage is generally maximal. 
The imaged 1 mm segment of A originated from the common carotid artery, 
where no or minimal plaque formation is expected.
Figure 1: Overview of tissue samples. Five segments from carotid endarterectomy 
specimen 1 (P1), one segment from carotid endarterectomy specimen 2 (P2) and, one 
segment from the autopsy carotid (A). Number of MALDI-MSI measurements and 
adjacent histological stains
All 1 mm segments were embedded in 10% porcine type A gelatin and 
cryo-sectioned (CM3050 S, Leica Biosystems (cutting temps: OT -21°C; CT 
-19°C)), into 10µm sections which were then thaw mounted onto non-conduc-
tive glass slides. After sectioning, the slides were stored at -80°C until imaging 
or histological staining. Per segment, 6 sections were imaged; the distance be-
tween MALDI-MSI sections was 30-50 µm. All sections were imaged or stained 
within 2 months after sectioning. 
Prior to imaging, the slides were desiccated under vacuum at room tempera-
ture for 10 minutes. The matrix, 2,5-dihydroxybenzoic acid (DHB), was applied 
using sublimation (home-built sublimation system as described in Dekker et 
al.23) at 125°C for 10 minutes; 50 mg of DHB was dissolved in 5 ml acetone. No 
washing, re-crystallization, or addition of ionization agents was used.
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Histological staining
Histological staining was performed on adjacent slides, which were histochemi-
cally stained by Hematoxylin-Eosin (HE), Oil Red O (ORO) and Resorcin-Fuchsin 
(RF) staining, to visualize general structure, lipids, and collagen and elastin, 
respectively. Immunohistochemical (IHC) staining was performed to visualize 
endothelial cells and macrophages. The slides imaged with MALDI-MSI were 
stained by ORO after MSI.
We assessed the plaque tissue according to the plaque classification scheme 
of Virmani et al. 2,3 and examined the tissue for features of plaque vulnerability 
(i.e. necrotic core, calcification, thrombus). We also assessed the tissue’s struc-
tural variability over consecutive tissue sections that originate from the same 
1mm segment. We used the histopathological data as a guidance to interpret 
the MALDI-MSI data.
Data acquisition
MALDI-MSI was performed on a MALDI-q-TOF mass spectrometer (Waters 
Synapt G2Si-TOF, Manchester, UK), operated in positive mode, at the instru-
ment’s “resolution mode” (single-pass reflectron TOF) with a spatial resolution 
of 50 µm. An Nd:YAG (355 nm) laser was operated at 2,000 Hz, at 50% of the 
maximum laser energy available (250/500 laser energy). At this energy level, 
the laser spot was ≈40µm in size. The mass range was 300-1,200 m/z and the 
scan time per pixel was 0.5 seconds using a left-right scanning pattern. The 
data was acquired using MassLynx v4.1 software (Waters, Manchester, UK) and 
HDimaging v1.4 software was used to export the data to imzML format. Prior to 
imaging, the machine was calibrated with red phosphorus spotted onto a steel 
plate. 
Mass identification
For the identification of the various lipid components, lipids were extracted 24 
by homogenizing 5 mg of tissue in 250 µL of Milli-Q water. The tissue was taken 
between sections P1-4 and P1-5. 10µL homogenized sample was combined 
with 10µl 10% TEA solution (trimethylamine (10/90, v/v) in methanol/dichloro-
methane (DCM) (50/50, v/v)) and mixed thoroughly. Subsequently, 450µl 
methanol/DCM (50/50, v/v) was added to this mixture. Samples were incuba-
ted on the roller bank for 30 minutes at 4°C. After incubation, samples were 
centrifuged at 14,000 rpm for 20 minutes at 4°C. Supernatant was transferred 
to a glass vial, and freeze dried until further use. 
The extract was subjected to high resolution MS for accurate mass data and 
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MS/MS experiments for structural information, as described in Angel et. al 
(2016)25. Ten µL of the extract was mixed with 190µL of a methanol/chloroform 
(1/1, v/v) mixture and infused at a rate of 240µL/hr. In a second set of expe-
riments, ammonium acetate was added to efficiently detect the cholesteryl 
esters (CE), a 10µL of the extract was mixed with 180µL of a methanol/chloro-
form (1/1, v/v) and 10µL of a 10mM ammonium acetate solution was added; 
the cholesteryl esters appear as NH4
+ adducts 26. 
High resolution mass data were obtained with an LTQ Orbitrap XL mass spec-
trometer with an electrospray ion source operated in the positive ion mode 
using the following settings: source voltage 4~kV and capillary temperature 
300°C. In such experiments, the analyte molecules appear as [M+H]+ or as 
[M+NH4]
+ species, whereas in MALDI imaging experiments they are usually 
cationized by residual Na+ and/or K+. Peaks within 2 ppm of the expected m/z 
values were taken into consideration for identification by MS/MS experiments.
For lipids such as the phosphatidylcholines (PC) and sphingomyelins (SM), pro-
duct ions in MS/MS spectra (for example m/z 184.1) may lie below the cut-off 
mass of the ion trap (27% of precursor mass). To circumvent such discriminati-
on effects and to reliably identify such species, MS/MS spectra were recorded 
on a triple quadrupole mass spectrometer, in our case an AB Sciex API-3000 
mass spectrometer operated in the positive ion mode, using the following 
settings: source temperature 200°C, capillary voltage 5.5kV and collision energy 
20V. 
Many of the ionized lipids undergo a common dissociation reaction giving a 
common product ion, for example m/z 369.3 for the CE and m/z 184.1 for PC 
and SM. In such cases a precursor ion scan (i.e. a scan of MS1 at fixed MS2) al-
lows the identification of the CE, PC and SM precursor ions. Thus, both PC and 
SM components are identified by setting MS2 at m/z 184.1, and then scanning 
MS1, whereas the CE molecules are identified by selecting MS2 at m/z 369.1, 
followed by an MS1 scan.  Such experiments were performed to identify all CE 
components using cholesteryl heptadecanoate (CE 17:0) as internal standard 
as described by Liebisch et. al (2006)26. The identified peaks were matched 
with the internally calibrated MSI data (Fig. 3) and identification was deemed 
positive if the masses agreed to within 2 ppm. Identified PCs, SMs and CEs are 
listed in supplementary information A.
Development of data processing pipeline
MSI data in the form of imzML files were loaded into MATLAB™ 2017a (Nat-
wick, USA) unbinned, resulting in dataset with 20,000 to 40,000 pixels per 
section, depending on the imaged area, and 79,413 mass bins. Data processing 
steps that were used to reduce this complex data set and retain the lipid spec-
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trum exclusively are described below.
Pre-processing 
Spectral processing imaging data
For each image pixel, the spectrum was smoothed using a second order Sa-
vitzky-Golay filter with a frame length of nine data points. After smoothing, 
a post-measurement calibration was performed using DHB cluster peaks as 
lock-mass and a linear fit, see Fig. 3. In Fig. 2 a representative mean spectrum 
of calibrated MALDI-MSI data is shown. 
Figure 2: Typical MALDI-MSI spectrum. P1-4 calibrated, mean spectrum, non-
normalized
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Figure 3: Flowchart of MSI data processing, showing the consecutive data processing 
steps of the MSI data. The number of m/z data points is reduced from 80,000 to 
200-400 by peak picking, elimination of non-lipid peaks, and cross-correlation-based 
background filtering. Also the number of informative pixels is reduced from 20,000 to 
7,500
Peak-picking
We perform peak-picking to make a pre-selection of the most important featu-
res of the data, for which we used the base peak (BP) spectrum because of the 
heterogeneous nature of our samples. The BP spectrum shows for each m/z 
value its maximum intensity measured over the entire MSI dataset 27.  Thus, the 
BP spectrum allows for detection of high intensity lipids that are only present in 
a small region. After calibration the BP spectrum was computed for the entire 
image and exported to mMass v5.5.0 28. We performed peak-picking in mMass 
by: (1) smoothing (Savitzky-Golay filter: window size 0.1 m/z and 2 cycles), (2) 
baseline correction (precision 15, relative offset 25), and (3) peak-picking (S/N 
threshold 10.0, peak-picking height 80%), see Fig. 3. The filter settings used 
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in this process were chosen heuristically: the additional peaks that are selec-
ted with less restrictive parameter settings are found to be removed in later 
processing steps. This supports the internal consistency of the work flow we 
propose here. The peak list was exported as a text file. 
Imaging data processing
TIC-normalization and peak matching
The calibrated imzML measurement and the peak list were imported into 
MATLAB™ (The MathWorks, Natick, MA, USA). The data was normalized using 
Total-Ion Current (TIC) normalization, see Fig. 3. The peak list exported from 
mMass was used to make a pre-selection and to that aim, the peaks of the 
mMass-derived peak list were matched to the MSI data. The peak list was ge-
nerated in mMass because the mMass peak-picking algorithm is better suited 
to process mass spectrometry data than the MATLAB findpeaks algorithm. 
For instance, in mMass the noise level is calculated locally and adjusted for 
every m/z value, which results in fewer false-positive peaks compared to the 
findpeaks algorithm of MATLAB.
Because the data processing pipeline was developed in MATLAB, the peaks of 
the mMass-derived peak list were matched to the MSI data imported in MAT-
LAB. Using the findpeaks algorithm of MATLAB™ the peaks in the mean TIC 
normalized spectrum of the image were detected. Subsequently, these peaks 
were matched to the peaks found in the mMass BP spectrum with a mass 
tolerance of ±0.02 m/z; this resulted in ≈600 peaks. The data was subsequently 
binned around these peaks, with a bin width of ±1 data point. The sample pitch 
of the TOF mass analyzer used varied with mass-to-charge ratio, increasing 
from ±0.0075 m/z at 300 m/z to ±0.015 m/z at 1,200 m/z. 
Lipid fractional mass filter
At this point, the dataset contains only the 600 most intense m/z peaks, which 
includes the lipids of interest as well as background and other non-lipid ions. 
To eliminate these unwanted signals, we applied several data reduction steps, 
aiming to maintain only lipid-representing m/z values. First, we applied a lipid 
fractional mass filter 27,29 to remove non-lipid peaks from the dataset. Masses 
that have a fractional mass outside the lipid fractional mass boundaries cannot 
be lipids and are therefore discarded, see Fig. 4.
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Figure 4: Lipid fractional mass filter. Masses outside the lipid fractional mass 
boundaries cannot be lipids
Cross-correlation-based peak selection
Subsequently, we performed peak selection based on background peaks to 
remove non-biological m/z values, similar to Fonville et al.30. In this method 
the correlation of images with a background reference peak was used to find 
matrix-related peaks and embedding medium-related peaks. Only masses that 
correlated negatively with this background reference mass were retained. The 
reference mass was chosen upon visual inspection; for all samples we used 
419.2 m/z as the background reference mass, see Fig. 4 step 5. Features that 
are important for choosing a good reference mass are: (1) high intensity in 
background area, (2) low intensity in tissue area and, (3) smooth transitions 
between the two areas.
We use the background reference mass and compute the cross-correlation 
using the Pearson correlation coefficient;
We then took the 9 highest correlations to this reference mass and used these 
to calculate the reference to all masses in the spectrum. We then calculated 
the mean correlation of all these 10 references. If this was negative a mass 
would be marked as being non-background and retained. This step reduced the 
number of m/z values to 200-400 peaks.
For sections with highly calcified regions, as were present in P1, an extra 
processing step was necessary due to noise allocated to the presence of these 
regions. This additional step is further explained in the supplementary informa-
tion B. 
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Area of interest selection
After elimination of the background and non-lipid peaks, we used a K-means 
clustering algorithm with N=2 clusters to identify lipid-rich tissue areas, see Fig. 
5a. Small gaps in the data were filled by first dilating the positive structures in 
the image with a six pixel circular kernel (MATLAB™ function imdilate), see 
Fig. 5b, and subsequent removal with the same kernel (imerode), resulting in 
a continuous region of interest for lipid analysis, see Fig. 5c. 
Figure 5: Pixel classification. a. Pixel selection based on K-means clustering (yellow) 
(N=2), b.Dilated pixel selection to ensure continuity (gray), and c.Final continuous pixel 
selection.
This selection of pixels containing lipid-rich tissue was additionally used to re-
move the last background peaks, by discarding masses that were more intense 
in the background pixels than in the lipid-rich tissue pixels. The combination of 
data processing steps reduced the datasets to 3,000-14,000 pixels, depending 
on section size, and 200-400 m/z values per measurement. 
Reproducibility
With the data processing pipeline presented here, we intend to compare lipid 
profiles along the length of the carotid artery within a patient and between dif-
ferent patients. Therefore, we need to estimate the variability between experi-
ments and the biological variation within the samples.
The coefficient of variation (CV) is a standardized measure for the variability in 
relation to the mean of the population, and was previously applied in MSI by 
Tillner et al.31,32. It is defined as the ratio of the standard deviation of a popula-
tion(σ) to the mean of a population (µ):  , expressed as a percentage. CV is in-
variant to the size of the population which makes it applicable to our relatively 
small dataset of six sections per segment 33. Also, CV is applicable to data with 
a wide variation in mean values, which is the case for our MSI dataset. The CV 
represents population variability: the lower the CV in a set of repeated experi-
ments, the higher is the reproducibility of the MSI measurement.
The quantitative reproducibility of these MSI datasets depends on the repeata-
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bility of the measurement, which includes instrument parameters but also the 
stochastic ionization process and efficiency of transfer into the analyzer, the 
heterogeneity in the sample as prepared for imaging, and variability between 
the sections within one segment. We assessed the baseline reproducibility of 
the instrument by spotting two lipid standards on top of homogenized carotid 
artery tissue. 2 μL of ≈1000 pmol/μL PC 17:0/17:0 and 2 μL of ≈1560 pmol/μL 
CE 17:0 were spotted onto the homogenate. Both lipid standards were spotted 
and measured six times with the instrument settings reported in the methods 
section and from that data we calculated the CV value. 
After data reduction, the tissue image dataset contains 200-400 m/z values, 
however, this data selection still contains isotopes. When calculating the CV, we 
used the de-isotoped m/z values (≈160) to avoid bias of similar isotope peaks. 
Every segment contains six tissue sections of which we calculate the mean 
intensity of the lipid-rich pixels for every m/z value. Resulting in 6 × 160 mean 
intensities, making up 160 populations for which we calculate the CV. We then 
calculated the mean CV value for every dataset () to allow comparison between 
the different segments. 
We used the histopathology images to verify if all 6 sections within one seg-
ment were the same from a morphological perspective. 
Results
Reproducibility
We found that the CV of the measurement of the lipid standard PC(17:0/17:0), 
is 10% for [M+H]+, 8% for [M+Na]+ and 16% for [M+K]+ . For cholesteryl esters 
we only looked at [M+Na]+,  since it is the only ion that is stable in time of 
flight 34, and we found a CV of 16%. The relative intensity of the PC [M+H]+ peak 
is about 100 times higher than that of PC [M+K]+ and CE [M+Na]+, which have 
about the same relative intensity. This means that PC [M+H]+ is less susceptible 
to the influence of noise on the signal, explaining the lower CV value. 
In the imaging data, tissue structure and content was not apparently different 
in the series of histologically stained sections within 1 mm segments. We thus 
assume that the CV values per segment represent MALDI-MSI measurement 
variability and not biological variability.
Fig. 6 shows the CV distribution of all measured segments. P2 shows the lo-
west of 12%, also P1-1, P1-2, P1-4 and P1-5 show relatively limited variability 
ranging from 14 - 25% for  Furthermore, P1-1, P1-2 and P1-4 show some m/z 
values with a higher CV; most of these peaks could not be identified. P1-3 and 
A show significantly higher values of 44% and 40%, respectively. Computing the 
total variability across all peaks in all datasets without matching the segments, 
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results in a  of 54%.
Furthermore, we expected to find that  would be lower when only comparing 
adjacent sections (30-50µm apart), since biological variation between these 
sections is relatively minimal. Also we hypothesized that two sections that were 
measured on the same glass slide, and thus have had the exact same sample 
preparation and storing conditions, would show a lower . However, we did not 
find these conditions to influence .
Figure 6: Coefficient of variation calculated using the mean intensity of every m/z 
value and comparing these values over all six measurements per segment. The mean 
CV value across the m/z values is given, and depicted as a horizontal line. The different 
assigned lipid classes have been clustered and are color coded. a. P1-1, b. P1-2, c. P1-3, 
d. P1-4, e. P1-5, f. A, and g. P2.
Relation between lipid content and plaque phenotype - preliminary 
observations
We hypothesize that the lipid composition of a plaque reflects plaque pheno-
type, and therefore expect to find specific lipid signatures in phenotypically 
different plaque structures. In our dataset we could examine thrombus, a key 
component in ischemic events, and changes in lipid profile occurring with deve-
lopment stage. 
Thrombus
Segment P1-4 contained thrombus, see Fig. 7c, in which monoacylglycerols 
(MAG), diacylglycerols (DAG) and, triacylglycerols (TAG) were abundantly 
present. When we compared 300x300 µm regions of interest (ROIs) in tissue 
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segments, we found the DAGs to be more abundant in the thrombus region 
of P1-4 compared to another region in the same segment and also compared 
to other segments and other tissue samples. As such, a high concentration of 
DAGs appears to be thrombus-specific. In Fig. 7 an example of the distribution 
and intensity of DAG 34:2 is shown, in comparison to the other tissue sections 
measured. In the supplementary information C, a list of all peaks assigned as 
DAGs with distributions similar to DAG 34:2 are given.    
Figure 7: Distribution of diacylglycerol (DAG) 34:2 (m/z 575.51) a. Boxplot of average 
intensity of diacylglycerol (DAG 34:2, [M+H-H2O]+) in a 300x300 µm region of interest in 
tissue segments. Expression in the thrombus-containing ROI of segment P1-4 (P1-4 Thr) 
is highly elevated, b. MALDI MSI of P1 segment 1 and 4. The thrombus region is outlined 
in cyan  c. ORO staining of MALDI section and HE staining of adjacent section indicating 
thrombus
Plaque development stage
The autopsy sample (sample A) contained a small fatty streak, which is an early 
manifestation of atherogenic changes in the vessel wall, as can be seen on the 
histological staining Fig. 8e, f and g. This sample was marked as an early stage 
plaque whereas the two CEA samples, P1 and P2, were advanced atheroscle-
rotic plaques. We compared the differences in abundance of prominent lipid 
peaks between early- and late stage disease, and found that the early lesion 
is significantly enhanced in cholesteryl oleate, whereas the advanced plaques 
exhibits higher concentrations of cholesteryl linoleate, see Fig. 8a and Fig. 8c.
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Figure 8: Distribution of cholesteryl linoleate (m/z 671.57) and cholesteryl oleate (m/z 
673.59) a. MALDI MSI of CE 18:2 in autopsy sample, P1-1 and, P2, b. MALDI MSI of CE 
18:1 in autopsy sample, P1-1 and, P2, c. Box plot of maximum intensity (99th percentile) 
cholesteryl linoleate  (CE 18:2), with over-expression in advanced plaques (P1 and P2), 
*p-value<0.0005, d. Box plot of maximum intensity (99th  percentile) cholesteryl oleate 
(CE 18:1), with over-expression in early plaque (Autopsy),  *p-value<0.0005,  e.  Oil Red 
O staining of MALDI MSI section, showing fatty streak, f. Immunohistochemistry CD68 
stain (zoom, adjacent section), showing macrophages in fatty streak g. HE stain (zoom, 
adjacent section), showing fatty streak
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Discussion
In this study, we composed a framework to investigate the lipid content of hu-
man carotid atherosclerotic plaques. Arterial tissue was systematically proces-
sed for both MSI and histology, ensuring that MSI findings could be contextu-
alized in terms of histopathology. Also, the data-processing pipeline presented 
here,  can effectively and reproducibly assess the complex MALDI-MSI dataset 
in a way that focusses on the lipid distribution in the relevant tissue locations.
Our protocol differs from previous MALDI-MSI studies on human atheros-
clerotic tissue 13,17-19 in the following ways. To our knowledge, this is the first 
study in which multiple carotid artery plaque specimens have been measured 
by MALDI-MSI. Based on this collection of carotid artery measurements, we 
optimized our data processing protocol. We have observed that the settings for 
discriminating tissue signal from background signal by negative cross-correlati-
on, are dependent on the composition of the tissue investigated, in particular 
the presence of calcifications. We expect that this data-processing step may 
need to be adjusted when investigating other arterial beds, the method allows 
these adjustments. Secondly, this is the first MSI study on arterial tissue that 
allows measuring both differences between- and within-specimen lipid content 
and determines intra and inter variations in the tissue. Finally, we quantified 
the reproducibility of the samples.
We designed the data processing pipeline to be easily adjustable for other 
MALDI-MSI research purposes. We processed the data to the standard imzML 
format, which is supported by all MS instruments. Moreover, the processing 
pipeline is generated in mMass and MATLAB, which are both software packages 
in common use and easily available. The design of our processing pipeline ma-
kes the method applicable and adjustable for research in other labs.
We quantified the variability of the MALDI-MSI measurements by determining 
the coefficient of variation for the 6 tissue sections measured per segment.  va-
ried between 12-44%, with an average value of 25%. Two segments, P1-3 and 
A, showed relatively larger variability which may be attributed to different fac-
tors. In the case of segment P1-3, there were large calcifications present in the 
sample. This influenced the quality and amount of tissue per glass slide, which 
can be seen from the K-means pixel segmentation of these sections shown in 
the supplementary information D. These large variations in sections most likely 
contribute to an elevated CV. 
In the case of segment A, this tissue is biologically different from P1 and P2, 
because it also contains the outer vessel wall layers, i.e. the tunica media and 
tunica adventitia. These layers are typically not as lipid-rich as the intimal layer. 
Therefore, the MALDI-MSI signal is much lower in these areas, resulting in a lo-
wer mean intensity value. When the mean values in the population are smaller, 
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the CV becomes more sensitive to relatively small changes. Also, differences in 
sample collection may have had an -- unknown -- impact. These results indicate 
that, in sections of lipid-rich atherosclerotic plaque, this protocol allows us to 
achieve a quantitative accuracy of approximately 12-20% for abundant lipids, 
which sets a lower limit for the detection of individual, local, or longitudinal 
variations in lipid profile.
Our analysis of three carotid plaque samples indicates that abundance of 
specific subtypes of cholesteryl esters may be related to atherosclerotic disease 
stage. Several studies have associated the presence of cholesteryl oleate (m/z 
673.59) with early stage plaques 35-40. Our MALDI-MSI data also showed sig-
nificantly higher cholesteryl oleate intensity in the early plaque of sample A, 
compared to the advanced plaques in the CEA tissue specimens. In addition, 
cholesteryl linoleate (m/z 671.57) has been shown to be more abundant in 
advanced plaques, compared to early stage plaques 41. While our limited num-
ber of samples does not allow us to draw quantitative conclusions, strikingly, 
we find cholesteryl oleate-to-linoleate ratios that are in close agreement with 
previous literature 42.
In our dataset, we also observed relatively high signal of DAG species in throm-
bus tissue. With the current dataset we cannot rule out the possibility that 
these DAG molecules represent fragmented TAGs. However, relative intensities 
of MALDI-MSI data of DAG molecules were different for thrombus compared 
to other segments, whereas their presumed TAG precursor molecules did not 
show this trend, indicating that we might be observing original DAG molecules, 
not TAG fragments. DAGs have at least two roles in biology, first, as an inter-
mediate molecule for the synthesis of TAG and phospholipids, and second, as 
a regulator of protein kinase C (PKC) isozymes, which modulate several cellular 
processes43. Accumulation of DAGs has been associated with diabetes, cancer 
and cardiovascular disease 44. PKC isoforms have also been associated with pla-
telet activation and phosphatidylserine (PS) exposure 45, underlining our finding 
of a high abundance of DAGs in a thrombus.
In this study we imaged 6 sections per segment and quantified the reprodu-
cibility of these sections, which is indicative for the minimum fold change in 
intensity necessary to be significant. In future studies, in which we plan to 
investigate a larger collection of specimens, it is therefore possible to reduce 
the number of sections per site that we measure. Together with the semi-auto-
mated analysis presented here, and technological advances such as continuous 
scanning modes, this makes it feasible to perform systematic analyses of mole-
cular lipid composition in larger sets of atherosclerotic specimens.
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In conclusion, we have developed a protocol for MALDI-MSI measurements 
of lipids in human carotid plaque tissue using a new analysis pipeline. This 
method can now be applied to larger collections of carotid plaque specimens, 
allowing to assess whether the carotid plaque’s lipid signature is correlated to 
plaque phenotype and vulnerability. If so, this opens up new opportunities in 
terms of diagnosis and patient stratification, and could enable the investigation 
of the effect of lipid-lowering medication on plaque composition and ruptu-
re-risk.
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A Supplementary information: Identified lipids in plaque
Table S1. Identification of phosphatidylcholines (PC) and sphingomyelines (SM) by high 
resolution mass spectrometry (orbitrap) and MS/MS (triple quadrupole)
Experimental massa Calculated mass 
[M+H]+b
Delta 
(ppm)c
Identification by MS2 d
369.35175 369.35156 
[M-H2O+H]+
-0.5 cholesterol
703.57471 703.57487 0.2 SM 16 18 1
725.55659 725.55922 3.6 Identified as [M+Na]+
731.60597 731.60617 0.3 SM 18 18 1
734.56912 734.56938 0.4 PC 16 16 0
758.56916 758.5694 0.3 PC 16 18 2
760.58483 760.58504 0.3 PC 16 18 1
780.55191 780.55373 2.3 Identified as [M+Na]+
782.56889 782.56938 0.6 PC 18 18 4
784.58494 784.58503 0.1 PC 18 18 3
786.60048 786.60068 0.3 PC 18 18 2
788.61586 788.61633 0.6 PC 18 18 1
810.60037 810.60068 0.4 PC 18 20 4
813.68395 813.68437 0.5 SM 18 24 2
a. Experimental mass (Orbitrap) for protonated species
b. Calculated mass (http://www.lipidmaps.org/tools/structuredrawing/GP 
masscalc.php) for protonated species
c. Difference calculated and experimental mass (in ppm)
d. Identification by exact mass and MS/MS data (triple quadrupole). Numbers 
refer to chain lengths and number of unsaturations (e.g. SM 16 18 1 represents a 
sphingomyeline with one C16 and one C18 chain and one double bond; position double 
bond(s) not determined)
Table S2. Identification of phosphatidylcholines (PC) and sphingomyelines (SM) Na+ 
adducts by high resolution mass spectrometry (orbitrap) and MS/MS (triple quadrupole)
Experimental massa Calculated mass 
[M+Na]+b
Delta 
(ppm)c
Identification by 
MS2 d
725.55659 725.5568 0.3 SM 16 18 1
780.55191 780.5514 -0.7 PC 16 18 2
a. Experimental mass (Orbitrap) for Na+ adduct
b. Calculated mass (http://www.lipidmaps.org/tools/structuredrawing/GP 
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masscalc.php) for Na+ adduct
c. Difference calculated and experimental mass (in ppm)
d. Identification by exact mass and MS/MS data (triple quadrupole). Numbers 
refer to chain lengths and number of unsaturations (e.g. SM 16 18 1 represents a 
sphingomyeline with one C16 and one C18 chain and one double bond; position double 
bond(s) not determined)
Figure S1. Delta (ppm) as function of mass for Table S1 and Table S2
Table S3.Identification of cholesteryl esters (CE) by triple quadrupole (precursor ion scan)
Experimental massa Calculated mass 
[M+NH4]+
b
Identification by MS2 c
614.6 614.5870 14:0
628.6 628.6026 15:0
640.6 640.6027 16:1
642.6 642.6183 16:0
654.6 654.6183 17:1
656.6 656.6340 17:0
666.6 666.6183 18:2
668.7 668.6340 18:1
682.7 682.6497 19:1
684.7 684.6653 19:0
696.7 696.6653 20:1
698.7 698.6809 20:0
716.5 716.6340 22:5
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a. Experimental mass (triple quadrupole)
b. Calculated mass (http://www.lipidmaps.org/tools/structuredrawing/GP 
masscalc.php) for NH4+ adduct
c. Peak present at mz 369.3 in precursor ion scan
B Supplementary information: Calcifications
Inspection of the images after filtering the background peaks, the retained 
lipid-rich peaks revealed areas of prominent chemical noise 1 associated with 
calcifications in the tissue as seen in histopathology, see Figure S2. Calcified 
tissue is often present in advanced atherosclerotic plaques. This hard material 
causes sectioning artefacts and has a limited adhesion to the glass slide. We hy-
pothesize that the non-planarity and poor thermal coupling affect the observed 
peak structure.
After the first selection round, with the first reference mass, the masses remai-
ning in the dataset are slightly different per dataset. This is due to the a-speci-
fic distributions in the images associated with calcifications, which cause the 
correlation of these images with our first reference mass to be located around 
the threshold value, causing erratic performance of this filter step. For this re-
ason, it was not possible to select one specific reference mass to remove these 
peaks in all measurements. Consequently, for each measurement we determi-
ne a second reference mass by finding the most negatively correlated mass in 
comparison to a number of highly abundant lipids in the samples. These highly 
abundant lipids are stated in Table 1.
Table 1: Highly abundant lipids in all samples
m/z Ion Peak assignment
369.35 [M-H2O+H]
+ Cholesterol
603.54 [M-H2O+H]
+ Diacylglycerol (DAG) 36:2
671.57 [M+Na]+ Cholesteryl ester (CE) 18:2
703.57 [M+H]+ Sphingomyelin (SM) 34:1 
725.56 [M+Na]+ Sphingomyelin (SM) 34:1 
782.57 [M+Na]+ Phosphatidylcholines (PC) 34:1
804.55 [M+Na]+ Phosphatidylcholines (PC) 36:4
881.76 [M+Na]+ Triacylglycerol (TAG) 52:2
The second background mass was only accepted if it was highly anticorrela-
ted to at least six of these eight lipids. With this second background mass, 
the same algorithm as with the first background mass was applied, and again 
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only masses with a negative correlation to this second background peak were 
retained.
Figure S2. Examples of noise resulting from calcified regions in P1-1 and P1-4
C Supplementary information: Diacylglycerols in thrombus
Table S4. Diacylglycerols (DAG) associated with thrombus area
m/z [M-H20+H]+ Peak assignment
549.49 DAG 32:1
551.50 DAG 32:0
573.49 DAG 34:3
575.50 DAG 34:2
577.52 DAG 34:1
579.53 DAG 34:0
599.50 DAG 36:4
601.52 DAG 36:3
603.53 DAG 36:2
605.55 DAG 36:1
607.57 DAG 36:0
623.50 DAG 38:6
625.52 DAG 38:5
627.53 DAG 38:4
629.55 DAG 38:3
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Figure S3. Distribution of all diacylglycerols(DAG)
D Supplementary information: Variability sections P1-3
Figure S4. Lipid-rich tissue pixels, selected by K-means, for all P1-3 sections.
1. Krutchinsky AN, Chait BT. On the nature of the chemical noise in MALDI mass spectra. Journal of the 
American Society for Mass Spectrometry. 2002;13(2):129-34.
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Chapter 7 General discussion 
This thesis aims at visualizing hemodynamic and tissue compositional patterns 
in highly stenotic carotid bifurcations. We focused on two characteristics of 
plaque pathology that could be indicative of the vulnerability of the plaque: 
the distribution of WSS over the plaque surface and the molecular lipid content 
of the plaque. This thesis is subdivided in two parts, that both initiate with the 
description of an image registration and data processing pipeline to assess the 
correlation between plaque composition and either WSS (Chapter 2) or spatial 
lipid distribution (Chapter 5). These pipelines were applied on two datasets of 
human advanced carotid plaques (Chapter 3 and 6). In addition we reported 
the spatial and temporal changes in WSS distribution during plaque progressi-
on in mice (Chapter 4).
This Chapter first discusses the main developments of this thesis in terms of 
image registration and data processing pipelines. Next, the main findings with 
respect to the correlation of both WSS and lipid patterns with compositional 
characteristics of plaque vulnerability are discussed and put into perspective.
7.1 Main developments of this thesis
7.1.1 Image registration framework for correlation of local WSS pat-
terns to plaque histology
When hemodynamic parameters and tissue compositional information are 
derived from different imaging modalities, accurate co-registration of the 
different imaging results is vital. Depending on the type of imaging modalities 
that need registration, rigid and/or non-rigid body transformations have to be 
taken into account. We developed a method for registration of in vivo ather-
osclerotic vessel MR images, and their derived WSS patterns, to the composi-
tional images of the excised plaque. Correlation of 3D MR data with 2D axial 
histologic cross-sections required an image registration pipeline that consisted 
of multiple intermediate registration steps and encompassed rigid and non-ri-
gid registrations. Using this set of images, the 3D MRI geometry functions as 
ground-truth for 3D artery shape. The intermediate ex vivo and en face imaging 
steps are used to track tissue deformation occurring due to surgical excision 
and tissue processing. 
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Two important challenges when designing an image registration pipeline exist: 
1. The assumptions made in each registration step, in order to obtain an opti-
mal trade-off between registration accuracy and computing time, and 2. The 
careful evaluation of introduced tissue deformations, processing artefacts and 
registration errors, necessary to report a reliable comparison. 
Considering the assumptions for registration, the image resolution of the ima-
ging modalities should be critically assessed. In our study, the resolution of the 
in vivo MRI was lowest, making this imaging modality the most limiting in ob-
taining correct image registration. If clinical scan time allows this, this parame-
ter can easily be improved by higher resolution imaging sequences. Increasing 
in vivo MR resolution and/or adding additional MR sequences would improve 
the landmark-based registration of in vivo and ex vivo imaging modalities, that 
is, if movement artefacts between the in vivo sequences can be avoided. High 
imaging resolution enables the recognition of tissue characteristics in consecu-
tive imaging modalities, which greatly improves the accuracy of the registration 
step. Using landmark-based registration, as performed in our rigid registration 
steps, the set of points to be registered is sparse compared to registration 
based on full 3D images. Thus in terms of computation time, landmark-based 
registration allows for a very efficient (initial) registration 1.  
Our non-rigid registration steps were segmentation-based: we matched the 3D 
lumen segmentations of consecutive imaging modalities. As with the land-
mark-based registration, the input for this registration step were not the full 
images, but only the discretized 3D lumen segmentations. Again this resulted 
in relatively short computation time. The registration accuracy of segmentati-
on-based registration depends on the quality of the manually-drawn segmen-
tation. As the implemented MRI sequences were optimized to achieve a clear 
lumen visualization, segmentation of the lumen was a fairly simple task on all 
imaging modalities and this segmentation-based non-rigid registrations was 
not limiting for the finally achieved registration accuracy.  
In general, the inclusion of intermediate imaging modalities, i.e. ex vivo MRI 
and en face, in our pipeline improved the overall in vivo MRI-to-histology regis-
tration accuracy relative to registration without intermediate modalities. The 
use of intermediate imaging modalities has the advantage of adding additional 
levels of resolutions between in vivo MR imaging and histology, which reduces 
the likelihood that transformation parameters get trapped in local optima 2.
After the assumptions have been taken into account, their effect on the regis-
tration result need to be reported. In our case, no golden standard existed to 
assess the obtained registration quality of the complete pipeline. The validity 
of image registration frameworks can usually only be quantified by phantom 
studies, simulations or other registration methods 1. The performance of sub-
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parts of our registration framework could be tested by artificial perturbation 
of the imaging results and reverse registration 2. For instance, the 3D ex vivo 
MRI scan could be converted into slices with en face resolution and artificially 
introduced artefacts. We could subsequently register the original ex vivo MRI to 
these modified ‘en face-like’ images. The error between the original and recon-
structed MRI stack represents a measure of the ex vivo-to-en face registration 
accuracy. However, to what extent this simulated method approaches the real 
life situation remains a question 3. In addition, the combined performance of 
all registration steps of the pipeline is difficult to simulate. We therefore chose 
the approach of measuring the overlap between the registered images 3 by 
calculating Haussdorff distances between the lumen segmentations in different 
imaging modalities. Theoretically, assuming idealized input and perfect regis-
tration, the optimal registration accuracy that can be achieved by the complete 
pipeline should be in the order of magnitude of the coarsest imaging resolu-
tion. Indeed, we found that the axial registration accuracy of our pipeline, as 
reported by Hausdorff distances, was in the order of magnitude of the in vivo 
MRI resolution. In addition, we found that a simulated mismatch of one in vivo 
MRI slice did not alter the WSS-plaque thickness correlation and concluded, 
somewhat pragmatically and to the best of our knowledge, that the accuracy of 
our registration pipeline is sufficient to serve the purpose it was designed for. It 
should be noted however, that excision, decalcification and histological proces-
sing of the advanced carotid plaques led to deformations and artefacts in the 
images that the applied registration method could not account for. Thus, loss 
of data was to some extent unavoidable. On a more general note, the current 
pipeline involves too much steps to be feasible for use in large clinical datasets. 
If that is the aim, the pipeline requires more automation, which would imply a 
redesign of the registration process and probably a discarding of the interme-
diate imaging steps in exchange for more accurate in vivo MRI sequences. With 
time, technological improvements might allow higher in vivo imaging resoluti-
ons with only limited increase in clinical scan time.
The insights that applying this pipeline provided on the correlation WSS-histo-
logy in advanced human carotid plaques are discussed in 7.2.
7.1.2 Data processing pipeline for correlation of spatial lipid patterns to 
plaque histology
Compared to the WSS-histology image registration pipeline, the registration of 
MALDI-MSI-based spatial lipid patterns to histology was fairly straightforward. 
Namely, since both imaging methods were applied on 2D tissue cross-sections, 
registration of the imaging outputs only required a point-based rigid registra-
tion of the MALDI-MSI tissue section and the tissue section used for histology 
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segmentation (original axial distance ~10 µm). However, in terms of data 
processing, handling of this large multidimensional dataset was challenging. 
The data processing can be subdivided in multiple steps: 1. Spectral processing, 
2. Selection of tissue-specific, lipid m/z values and their identification, 3. Data 
compression and analysis, both unsupervised, i.e. histology-independent, and 
supervised, i.e. histology-based. Spectral processing of data is required for all 
mass spectrometry datasets, whether involving imaging or not, and has been 
studied extensively. This first processing step is necessary for removing all 
measurement-related variation and/or noise, that is not biologically relevant 
and involves baseline correction, normalization, calibration, smoothing and 
peak detection. The procedures have been thoroughly described in literatu-
re, also in the context of MALDI-MSI, e.g. in the reviews of Norris et al. and 
Alexandrov et al. 4,5. We performed a reproducibility analysis to quantify the 
non-biological measurement variability of our experimental setup and spec-
tral processing workflow. This was determined by calculating the coefficient of 
variation (CV) of each m/z value in our dataset. In the investigated dataset an 
average CV of 25% was found. However, the sections with lipid-rich plaques 
and little calcium-related tissue processing artefacts had an even lower CV for 
abundant lipids, i.e. 12-20%. Thus, for our population of lipid-rich advanced 
plaques, variations in lipid profile above this CV value are likely to be caused 
by individual, local or longitudinal biological variations. This is relevant infor-
mation when applying unsupervised data analysis approaches, since these 
data mining techniques are able to visualize group structures, e.g. lipid profiles 
characteristic of plaque components only when variation within-groups, e.g. 
measurement variability, is sufficiently small 6,7. Previously reported CV values 
using DHB matrix were in the order of magnitude of the average CV of our 
complete dataset 8,9, indicating that our sample preparation and spectral pro-
cessing pipeline achieves good quality data.
The second data processing step in our pipeline, i.e. selection and identification 
of tissue-specific lipid m/z values, performed well. That is, visual assessment 
of the m/z values and images that were retained in the dataset after filtering, 
showed that the selected lipids were indeed tissue-specific. The lipid species 
measured were determined by the choice of matrix and ionization polarity 
mode, as discussed in Chapter 1. In this first study, we measured in positive 
ion mode in combination with DHB matrix. We made this choice because DHB 
was the most commonly applied and reported matrix for cardiovascular lipid 
research 10 and was shown to be effective for visualization of a wide array of 
lipids in positive ion mode. In future, the lipid map of human atheroma can be 
systematically extended with the spatial information of other lipid classes, by 
implementing the developed pipeline on a new dataset using negative ionizati-
on mode and/or an alternative matrix. 
Based on literature reporting the measurements in both positive and negative 
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ionization mode in the same cardiovascular tissue samples, we expect to detect 
greater abundances of fatty acids 11,12, sphingomyelins 11 and phosphoinositols 
11,13 in negative mode compared to positive mode.
In addition, specific lipids have been found to be differentially present in plas-
ma samples of coronary artery disease (CAD) patients versus non-CAD patients 
14 and specific lipids might thus be associated with the development of symp-
tomatic disease. Targeted MS imaging of the presence and spatial localization 
of these lipids in advanced human plaques would also be very informative with 
respect to the identification of plaque vulnerability by plaque lipid content. This 
will be discussed further in 7.3.
As final data processing step, we applied both unsupervised and histology-ba-
sed data analysis approaches to visualize lipid patterns in our set of advanced 
carotid plaques. Unsupervised methods do not require prior knowledge of 
the data: their application is aimed at visualizing general data structure and 
identify regions that display correlated mass spectral profiles 5,15. A wide array 
of unsupervised classification algorithms have been proposed and tested on 
MSI data, as reported in excellent reviews 5,15,16. On our dataset we have tested 
multiple algorithms, e.g. principal component analysis (PCA), non-negative 
matrix factorization (NMF) and K-means clustering. Small differences were 
found in the spectral patterns yielded by the different algorithms. However, 
by the application of three independent classification algorithms on the same 
dataset, we found data structures that were identified by all three classification 
methods. In accordance with literature 16,17, we found that the data reduction 
results of K-means and NMF were easier to interpret than those of the PCA. For 
application of K-means, the number of clusters needs to be predefined, which 
makes this method not truly unsupervised, and its random initialization led to 
different cluster results each time the algorithm was run. After careful consi-
deration of the pros and cons per data analysis technique, we chose to apply 
NMF clustering on our dataset. NMF is an established data reduction approach 
for MSI data 16, the algorithm did not raise issues in terms of computational 
capacity and a model was available to calculate the optimal number of NMF 
components 18 before running the algorithm. We compared the outcome of 
the unsupervised NMF clustering with a multivariate analysis of histology-ba-
sed data. We found that the methods agreed in the lipid profiles that were 
associated with the largest tissue structural features, i.e. necrotic core and 
fibrin. Histology is regarded as the gold standard in tissue characterization. Our 
comparison between the two analyses and the found agreements indicate that 
in future, assessment of large MSI datasets might be performed unsupervised, 
without the need of time- and labor-intensive histological processing. Howe-
ver, this would require additional comparative studies, to increase the body of 
evidence of overlap between histologically-determined compositional featu-
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res and lipid profiles. In addition, the spatial lipid profile might complement 
the current views on plaque vulnerability characteristics, e.g the presence or 
absence of specific lipids might be correlated to a certain plaque phenotype 
or disease state. However, such features might be very subtle, and not easy to 
extract by the type of exploratory analyses that we performed here. Rather, 
large-scale targeted lipidomic profiling of plaque extracts could yield clues as to 
which lipid species should be selectively investigated. 
7.2 WSS and histological characteristics of plaque 
vulnerability
7.2.1 Findings in a cross-sectional study of human advanced carotid 
atherosclerosis
The existence and/or nature of the relation between WSS and compositional 
characteristics of plaque vulnerability in advanced atherosclerosis has been, 
and still is, a subject of debate. The image registration framework presented in 
Chapter 2, provided a measure to investigate this relation in human advanced 
disease. We found larger NCs at sites of high TAWSS. Also, we found low OSI to 
correlate with larger macrophage area and thicker caps, surprising findings that 
have not been reported before. Namely, these low OSI areas, unlike the general 
assumption, not always coincided with high TAWSS, and the effect of low OSI 
alone on the regulation of endothelial signaling pathways has, to the best of 
knowledge, not been studied yet. The composition of the intimal areas that 
were located within a depth of 250 µm or 400 µm from the lumen, was not 
correlated to local WSS patterns.
Investigating disease in human subjects naturally involves methodological 
constraints. As we aimed to investigate the relation between WSS metrics 
and histologically-determined plaque composition, we were designated to a 
cross-sectional study setup, providing information about one time point. Howe-
ver, as described in Chapter 4, it is assumed that, to unravel the effect of WSS 
on plaque composition, dynamic changes in WSS levels should be monitored, 
i.e. by assessing WSS at multiple time points. Thus ideally, the relation between 
WSS and plaque composition should rather be investigated in a longitudinal 
setup. At the same time, it could be argued that if two factors are strongly rela-
ted, evidence for this relation is also expected to crystallize in a cross-sectional 
study. We found relations between TAWSS and NC, which was in agreement 
with literature 19–21, and between OSI and macrophages and cap thickness. 
Caution should be taken with interpreting the found TAWSS-NC relation in this 
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cross-sectional setup. Namely, larger NCs are generally found in larger plaques 
and plaque size – partly - influences stenosis and subsequently WSS patterns, 
thus reflecting a chicken-and-egg problem that cannot be elucidated by stu-
dying one point in time. As for the relation of OSI with features of vulnerability, 
it would be interesting to extend this line of research, to find out whether OSI 
and TAWSS are independent metrics with respect to plaque vulnerability.
As plaque histology could only be obtained from subjects that were eligible for 
an endarterectomy procedure, the study population involved elderly patients 
with advanced disease. As argued above, relations between WSS and plaque 
composition might be dynamic and might be disease stage-dependent. Previ-
ously reported relations between TAWSS and vulnerability features, e.g. cap 
thickness or macrophage infiltration 22–24, might be less obvious in this elder-
ly group of patients. In advanced disease, the complex interplay of multiple 
processes and factors, e.g. solid and fluid mechanics, molecular processes and/
or lifestyle-related blood composition, might complicate the recognition of a 
one-on-one relation in this study setup.
In future applications of this pipeline, it might be interesting to replace our 
histology-based compositional measures, i.e. NC area, fibrin area, macrophage 
area and cap thickness, for compositional measures of vulnerability focused at 
the molecular level. For example by looking at inflammatory markers shown 
to be up- or downregulated in response to varying WSS levels 25. The applied 
registration framework can be of value in these kind of studies as well, e.g. by 
adding immuno-histochemical staining procedures for specific molecular mar-
kers, by implementing other types of molecular imaging of tissue sections, e.g. 
MALDI-MSI or laser-capture micro dissection, into the pipeline. 
7.2.2 Temporal and spatial developments in mice – translatable to the 
human situation?
To study the temporal changes in WSS distribution during plaque progression, 
a question that could not be answered by the cross-sectional human study 
presented in Chapter 2 and 3, a longitudinal study using an atherosclerotic 
mouse model was designed (Chapter 4). Atherosclerosis was induced in ApoE 
knockout mice by placing a flow-modifying tapered cast in the carotid artery. 
The interplay between disease progression, as measured by stenosis degree, 
and corresponding WSS distribution was monitored at three time points. Over 
time, animal-specific variations in disease progression were found, that were 
uncorrelated to the degree of stenosis at the start and end points of the study. 
Also, blood flow through the diseased arteries dramatically reduced over time 
in almost all animals. This led to the counterintuitive observation of progressi-
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ve lumen narrowing that was accompanied by decreasing absolute WSS levels 
over time. The notable conclusion of this study is the importance of taking into 
account both geometrical and flow information when studying WSS patterns, 
while many studies only look at geometry to make WSS assumptions. Whether 
the observed reduction in blood flow and concomitant decrease in WSS over 
time was inherent to this specific mouse model or a general pathological 
phenomenon, as it is related to the status of the distal vascular bed, is unclear. 
Previously-performed longitudinal studies in mice insufficiently report tempo-
ral and spatial changes in WSS during disease progression. In a recent longitu-
dinal study in pig coronary arteries, flow levels did not markedly change over 
time and the largest plaque progression was found in segments with low initial 
TAWSS that over time developed into high TAWSS 26. Though this study differed 
both in investigated vascular bed and in animal model, the results indicate that 
the observed dramatic decrease in flow and WSS over time in our study might 
be inherent to the mouse-cast model. Also, in human carotid arteries, WSS was 
mainly reported to increase over time 19,27,28.
Considering plaque growth, the plaque gradually developed upstream of the 
surgically-induced stenosis and axially progressed from distal to proximal over 
time. At each time point, the averaged WSS levels in the proximally-located 
healthy artery segment were lower than in the diseased segment, resulting in 
a positive correlation between TAWSS and plaque size. At the final time point, 
the correlation between histologically-determined plaque composition and 
WSS levels at the three imaging time points was investigated as well. Eccentric 
plaques with relatively large macrophage areas were found proximally, whereas 
closer to the cast larger concentric plaques with lower degrees of macropha-
ge infiltration were found. Thus, an inverse correlation between TAWSS and 
macrophage area was shown in almost all animals. In addition, a trend towards 
higher relative NC area at higher TAWSS was seen, as in the human CEAs in 
Chapter 3. However, direct translation of these results to plaque composition 
and WSS found in humans, is difficult. In general, atherosclerosis in mice is 
associated with more inflammation than in humans 29, which might explain 
the relation between TAWSS and macrophages observed in the mouse model, 
but not in the human CEAs. Secondly, the biomechanical environment in mice 
is completely different, e.g. the Reynold’s number differs 30, which directly 
influences WSS levels, and mouse vasculature experiences much lower stress 
compared to humans 31. Since other biomechanical factors were not taken into 
account, their influence on plaque composition in both studies further ham-
pers direct translation. While in the human CEA study, the use of patient-spe-
cific WSS tertiles was advocated above the use of absolute WSS values, in 
Chapter 4 animal-specific analysis of correlations was performed using absolute 
TAWSS values. 
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In the mouse study, the analysis could be performed using absolute TAWSS 
values because the ranges of TAWSS values were less wide, i.e. in the order of 
0-10 Pa, than in the human carotids.
7.2.3 Potency of WSS as biomarker or correlative factor reflecting pa-
thophysiology
What insights were gained from the combination of the cross-sectional human 
study and the longitudinal mouse model and how to proceed investigations 
in order to ultimately benefit clinical practice? Firstly, both studies point out 
that WSS is a factor that strongly depends on subject-specific geometry and 
flow conditions. Thus, general cut-off values, discriminating low, mid and high 
WSS, should not be aimed at. In addition, when including WSS at multiple 
time points, alterations in flow through the artery should also be assessed and 
taken into account. Secondly, though the found relations between local WSS 
and plaque composition varied, both studies stressed the spatial compositional 
heterogeneity of the plaque. This implies that future investigations should aim 
at achieving accurate co-localization of WSS and compositional information and 
limiting the degree of spatial averaging of WSS. 
Considering these two main insights from Chapter 3 and 4, and focusing on 
human carotid atherosclerosis, performing an MRI-based longitudinal study 
into the WSS-plaque vulnerability relation will be an interesting direction to 
head into. Presuming that in the near future MRI technology will fulfill its 
potential of achieving very high spatial resolution 32,33, this technique will allow 
sequential scanning of plaques, thereby unraveling the dynamic compositional 
effects of disease progression over time. Also, as MRI sequences for direct WSS 
assessment are improving 18, WSS and plaque composition can be derived 
from the same imaging modality, thereby undoing all current limitations of stu-
dies involving multiple imaging modalities. An important question that remains 
however, is what timeline should be considered to capture the dynamic effect 
of WSS on plaque composition in humans? In the mouse-cast model, WSS at 
4 and 2 weeks before histological assessment and at the time of sacrifice was 
monitored, but these numbers are difficult to translate to the human situation, 
as disease rate differs between mice and man. In the largest longitudinal cohort 
of coronary artery patients, mean follow-up time, determined by the occurren-
ce of clinical events, was 3.4 years 34. So when investigating advanced disease 
in a population comparable in age to the CEA population, we should consider 
designing a 4 year longitudinal study with yearly imaging time points to moni-
tor the dynamic interplay of WSS and plaque composition.  
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7.3 Lipid patterns and histological characteristics of 
plaque vulnerability
7.3.1 Potency of spatial lipid signal as biomarker for plaque compositi-
onal characteristics 
Chapter 6 describes a unique study, in which the spatial locations of almost 200 
lipids in human CEA samples are compared and correlated to the local histolo-
gically-determined plaque composition in order to find lipid species indicative 
of plaque phenotype. We were the first to perform this analysis on a set of over 
100 tissue sections, thereby gaining a wealth of information on both the inter- 
and intra-plaque variability in spatial lipid composition. As mentioned in 7.1, 
the choice of DHB matrix and positive polarity allowed for the visualization of 
an array of lipid classes that were recognized to play a role in atherosclerosis in 
earlier work 11,35. 
Generally, lipids belonging to the same lipid class showed similar spatial pat-
terns. Between lipid classes however, marked differences in distribution were 
observed. SMs and oxidized CEs, two lipid types that have been associated with 
plaque development before 35–40, were found to be significantly more abun-
dant in NC. In addition, DAGs and TAGs were found in higher concentrations in 
regions histologically associated with thrombus. These results are promising, as 
they indicate a relation between specific lipids and vulnerability features. 
Most studies investigating the lipid content of human atherosclerotic plaques 
have used CEA samples, as it is the most easily obtainable human plaque ma-
terial. However, the composition of these tissue samples represents advanced, 
often symptomatic, disease. For extending our understanding of the role and 
significance of lipids in atherosclerosis, there is need for comparison of lipid 
profiles at different disease stages, as well as in stable versus unstable disease. 
In early studies, different disease stages have been characterized by varying re-
lative ratios of lipid classes. That is, with plaque progression, the ratio esterified 
cholesterol to total cholesterol was found to decrease, while the ratio sphingo-
myelin to phosphocholine increased 41–43. Since atherosclerosis is characterized 
by accumulation and local oxidation of lipids in the growing plaque, the degree 
and nature of oxidation products has also been compared between plaque 
stages 44. Disease progression was expected to be accompanied by increasing 
levels of oxidized phospholipid species, and the most advanced plaques were 
expected to show the most stable oxidation products. However, this pattern 
was not found in a study comparing oxidation products of the major phosp-
holipids in different plaque stages 44, indicating that atherosclerosis involves 
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a continuous process of lipid infiltration and peroxidation and that both for-
mation and degradation of early and advanced products of lipid oxidation are 
present in each plaque stage. In a study comparing spatial lipid distributions in 
human coronary plaque cross-sections, the spatial distribution of lipid classes 
was reported to differ depending on histologically-defined plaque stage 11. 
For studying stable versus unstable atherosclerosis, studies have focused on 
the lipid composition of blood plasma instead of plaque. As mentioned in 7.1.2, 
in large cohorts of CAD patients, specific phospholipids and sphingolipids have 
been associated with cardiovascular events 45–47 and can improve event risk 
prediction scores. Also, levels of distinct ceramide, phosphatidylinositol and 
phosphatidylethynolamine species were able to discern stable from unsta-
ble CAD 14. As relations have been suggested between plasma lipids and the 
condition of the vascular wall 48, it will be interesting to specifically image the 
spatial distribution of these reported lipid species in different plaque stages, to 
find out whether these lipid molecules are associated with features of plaque 
vulnerability.
All in all, there is substantial evidence for a relation between plaque vulnera-
bility and lipid profile, to which our MALDI-MSI study has significantly contri-
buted. The finding that specific lipids are more abundant in NC or thrombus is 
crucially informative for the development of new imaging techniques. Spectral 
photoacoustics (sPA), an imaging modality that can reveal lipid composition 
based on optical absorption, is a very suitable technique for imaging a plaque’s 
lipid profile. Using sPA, our findings can be translated to a clinical application 
able to improve assessment of a plaque’s rupture risk and treatment plan. 
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 Summary
Cerebrovascular events such as stroke can inflict sudden death or disability: 
either way they have a significant impact on personal lives as well as on socie-
ty. One of the underlying diseases leading to cerebrovascular events is carotid 
atherosclerosis. Decades of research have been devoted to unravelling the 
pathophysiology of this disease, however the developments that lead to plaque 
rupture and clinical symptoms are still not fully elucidated. Thorough under-
standing of the pathophysiology of atherosclerosis is important for disease ma-
nagement, e.g. prevention and therapy, as well as for early diagnosis of the pa-
tient at risk of an event. The work described in this thesis focused on advanced 
carotid atherosclerotic plaques and aimed at investigating two characteristics 
of plaque pathology that might be indicative of the vulnerability of the plaque. 
These two characteristics are 1. the distributed wall shear stress (WSS) patterns 
over the plaque and 2. the spatial distribution of lipids in the plaque. Both are 
compared to local tissue compositional characteristics of plaque vulnerability 
identified by histology, which is the current golden standard to obtain composi-
tional information. To achieve these goals we developed two image registration 
and data processing pipelines, that were applied on datasets of human carotid 
endarterectomy samples. This thesis is subdivided in two parts: In Part 1 the 
work aimed at investigating the correlation between local WSS patterns and 
histologically-determined tissue composition is described and in Part 2 histolo-
gically-determined plaque composition is correlated to spatial lipid patterns.
In Chapter 1 we provide the biological background of atherosclerosis. We 
explain the influence of hemodynamics on disease initiation and shortly review 
the current knowledge on the role of WSS in carotid atherosclerosis progres-
sion. We explain that lipids play a crucial role in the pathophysiology of ather-
osclerosis and might be indicative of plaque phenotype, which is why they 
embody a potential powerful diagnostic imaging marker.
To correlate local WSS levels directly to plaque compositional information 
derived from histology we developed an image registration pipeline, which is 
described in Chapter 2. The pipeline was designed to process imaging and his-
tology data of carotid endarterectomy specimens. Four types of images of the 
plaque were required as input: in vivo carotid MRI before surgery, ex vivo MRI 
of the excised plaque, en face photos of 1 mm thick axial cross-sections of the 
plaque, as well as the corresponding histology images of these axial cross-sec-
tions. By a series of rigid and non-rigid registration steps, these images were 
mapped to a shared 3D image domain. 3D WSS maps were generated based on 
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the MRI-derived in vivo artery geometry and patient-specific flow information. 
After successful registration, the axially-averaged WSS values were mapped in 
2D on the corresponding lumen locations of the histology sections. As a valida-
tion measure, we simulated the effect of an axial mismatch of one MRI slice on 
the relation between WSS and plaque thickness, and found that this relation 
was not significantly altered in the investigated cases.
The developed image registration pipeline was applied on a dataset of human 
carotid endarterectomy samples. The results of this study are described in 
Chapter 3.  We correlated local time-averaged WSS (TAWSS) and oscillatory 
shear index (OSI) values to plaque composition. Significantly larger NC areas 
were found at arterial segments exposed to high TAWSS. In addition, segments 
exposed to low OSI values had significantly more macrophages and a trend 
towards higher cap thickness at low OSI was observed. 
In Chapter 4 we described the temporal and spatial changes in WSS in an ApoE 
knockout mouse model of carotid atherosclerosis. Absolute WSS was found to 
significantly decrease with time, while the degree of stenosis increased. In ad-
dition, we investigated the relation between local WSS and histological plaque 
composition and found a positive correlation between WSS and plaque area 
and a negative correlation between WSS and macrophage content. Pooling the 
data of all animals nullified these correlations, demonstrating that analysis of 
individual cases is necessary for investigating WSS-plaque composition correla-
tions.
Part 2 of this thesis starts with Chapter 5, which describes a data processing 
pipeline to investigate the spatial lipid patterns in carotid endarterectomy 
samples using matrix-assisted laser desorption/ionization mass spectrometry 
imaging (MALDI-MSI). This pipeline was developed as a tool to investigate 
whether the spatial lipid profile of a plaque is indicative of plaque phenotype. 
We optimized sample preparation, data processing and data filtering to ob-
tain a reproducible workflow for visualizing lipid distributions in carotid tissue 
sections and to contextualize these findings in terms of histology. In a series of 
tissue sections, we found that diacylglycerols were more abundant in a throm-
botic area. Also, we found that the ratio of cholesteryl ester (CE) oleate and CE 
linoleate was indicative of plaque phenotype.
In Chapter 6, the pipeline developed in Chapter 5 was applied on a dataset of 
human carotid endarterectomy samples. The resulting data, containing both 
spectral and spatial information, was analyzed by unsupervised classification 
as well as by an histology-driven multivariate approach. Both methods identi-
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fied an increased abundance of sphingomyelins and oxidized cholesteryl esters 
in necrotic plaque areas. In addition, diacylglycerols and triacylglycerols were 
associated with areas containing fibrin, a structural component of thrombus.
Finally, in Chapter 7 the main technological developments and biological fin-
dings of this thesis are discussed, as well as their contribution to the cardiovas-
cular research field.
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 Samenvatting
Een herseninfarct kan resulteren in ingrijpende lichamelijke beperkingen of 
in een plotseling overlijden. Beide scenario’s hebben een aanzienlijke impact 
op persoonlijke levens en op de maatschappij. Atherosclerose is één van de 
onderliggende oorzaken van een herseninfarct. Al decennia lang proberen we-
tenschappers de pathofysiologie van deze ziekte te ontrafelen, maar de ontwik-
kelingen die leiden tot plaque-ruptuur en klinische symptomen zijn nog steeds 
niet volledig in kaart gebracht. Een grondig begrip van de pathofysiologie van 
atherosclerose is belangrijk voor ziektebeheer, middels preventie en therapie, 
en ten behoeve van een tijdige diagnose van een patiënt met risico op een 
herseninfarct. Het werk dat in dit proefschrift wordt beschreven, was gericht 
op vergevorderde plaque vorming in de halsslagader (arteria carotis) en op het 
onderzoeken van twee kenmerken van plaque pathologie die een aanwijzing 
kunnen zijn voor de ruptuurgevoeligheid van een plaque. Deze twee kenmer-
ken zijn 1. De verdeling van de wandschuifspanning (WSS) over een plaque en 
2. de spatiële verdeling van lipiden in een plaque. Beide kenmerken worden 
afgezet tegen lokale plaque componenten die eerder gecorreleerd zijn aan de 
ruptuurgevoeligheid van een plaque. Deze componenten worden zichtbaar ge-
maakt middels histologie, de huidige gouden standaard om plaque compositie 
in kaart te brengen. Om dit te kunnen doen, ontwikkelden we twee beeldregis-
tratie- en data verwerkings-methoden, die werden toegepast op datasets van 
humane carotis-endarteriëctomie specimens. Dit proefschrift is onderverdeeld 
in twee delen: in deel 1 wordt het werk beschreven dat gericht is op het onder-
zoeken van de correlatie tussen lokale WSS-patronen en histologisch bepaalde 
plaque compositie en in deel 2 het werk dat gericht is op het onderzoeken van 
de correlatie tussen spatiële lipidenpatronen en histologisch bepaalde plaque 
compositie.
In Hoofdstuk 1 wordt de biologische ontwikkeling van een atherosclerotische 
plaque beschreven. De invloed van hemodynamica op het ontstaan  van een 
plaque en de huidige kennis met betrekking tot de rol van WSS op de progres-
sie van een atherosclerotische plaque in de arteria carotis wordt uitgelegd. De 
cruciale rol die lipiden spelen in de pathofysiologie van atherosclerose wordt 
beschreven. Spatiële lipidenpatronen in een plaque zijn mogelijk indicatief voor 
de ruptuurgevoeligheid van een plaque en zouden daarom kunnen dienen als 
diagnostische marker. 
Om lokale WSS-niveaus direct te correleren aan weefselsamenstelling van de 
plaque, verkregen middels histologie, ontwikkelden we een beeldregistratie 
170
methode. 
Deze wordt beschreven in Hoofdstuk 2. De methode is ontworpen om beel-
dvormings- en histologie-data van carotis-endarteriëctomie-specimens te 
verwerken. Vier soorten afbeeldingen van de plaque waren nodig als input: in 
vivo carotis-MRI vóór de operatie, ex vivo MRI van de chirurgisch uitgenomen 
plaque, foto’s van 1 mm dikke axiale doorsneden van de plaque, evenals foto’s 
van de 5 µm dikke histologische coupes verkregen van deze axiale doorsneden. 
Door een reeks rigide en niet-rigide registratiestappen werden deze afbeeldin-
gen weergegeven op een gedeeld 3D-beelddomein. De WSS verdeling over de 
carotis werd berekend op basis van de in vivo geometrie verkregen met MRI en 
patiënt-specifieke bloedstroomsnelheid. Na succesvolle registratie werden de 
axiaal gemiddelde WSS-waarden in 2D weergegeven op de bijbehorende lumen 
locaties in de histologische coupes. Ter validatie simuleerden we het effect van 
een axiale mismatch ter grootte van één MRI cross-sectie op de relatie tussen 
WSS en plaque dikte, en ontdekten dat deze relatie in de onderzochte gevallen 
niet significant veranderde.
De ontwikkelde beeldregistratie methode werd toegepast op een dataset van 
humane carotis-endarteriëctomie-specimens. De resultaten van deze studie 
worden beschreven in Hoofdstuk 3. We correleerden de lokale, over de tijd 
gemiddelde WSS-waarden (TAWSS) en de oscillatoire shear index (OSI) aan 
plaque compositie. Significant grotere necrotische plaque gebieden werden 
gevonden bij arteriële segmenten die waren blootgesteld aan hoge TAWSS. 
Bovendien hadden segmenten die waren blootgesteld aan lage OSI waarden 
significant meer macrofagen en werd een trend waargenomen naar een hogere 
kapdikte bij lage OSI.
In Hoofdstuk 4 beschreven we de temporele en spatiële veranderingen in 
WSS in een muismodel van carotis atherosclerose (ApoE-/- met cast). Absolute 
WSS bleek significant af te nemen met plaque progressie, terwijl de mate van 
stenose juist toenam. Daarnaast onderzochten we de relatie tussen lokale WSS 
en histologisch-bepaalde plaque compositie en vonden we een significante 
positieve correlatie tussen WSS en plaque grootte en een significant negatieve 
correlatie tussen WSS en macrofaagdichtheid. Het middelen van de data van 
alle dieren maakte deze correlaties ongedaan, wat aantoont dat analyse van in-
dividuele gevallen noodzakelijk is voor het onderzoeken van correlaties tussen 
WSS en plaque compositie.
Deel 2 van dit proefschrift begint met Hoofdstuk 5, dat een data-verwerkings 
methode beschrijft om de spatiële lipidenpatronen in carotis endarteriëctomie 
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specimens te onderzoeken met behulp van matrix-geassisteerde laserdesorptie 
/ ionisatie massaspectrometrie beeldvorming. Deze methode is ontwikkeld om 
te onderzoeken of het spatiële lipidenpatroon van een plaque indicatief is voor 
de ruptuurgevoeligheid van een plaque. We hebben de weefsel preparatie, 
data verwerking en data filtering geoptimaliseerd om een  reproduceerbaar 
werkprotocol te verkrijgen voor het visualiseren van spatiële lipidenpatronen 
in coupes van humane carotis plaques en om deze bevindingen te relateren 
aan histologie. In een reeks weefselcoupes ontdekten we dat diacylglycerolen 
meer voorkwamen in gebieden met bloedingen. Daarnaast vonden we dat de 
verhouding van cholesterylester oleaat en cholesteryl ester linoleaat indicatief 
was voor de mate van ruptuurgevoeligheid van een plaque.
In Hoofdstuk 6 werd de in Hoofdstuk 5 ontwikkelde methode toegepast op 
een dataset van humane carotis endarteriëctomie specimens. De resulterende 
datasets, die zowel spectrale als spatiële informatie bevatten, werden geanaly-
seerd met een histologie-onafhankelijk classificatie algoritme en een door his-
tologie aangestuurde multivariate benadering. Beide methoden identificeerden 
een hogere hoeveelheid sphingomyelines en geoxideerde cholesteryl esters in 
necrotische delen van de plaque. Bovendien werden diacylglycerolen en tria-
cylglycerolen geassocieerd met gebieden die fibrine bevatten, een structureel 
onderdeel van trombus.
Tot slot worden in Hoofdstuk 7 de belangrijkste technologische ontwikkelingen 
en biologische bevindingen van dit proefschrift besproken, evenals hun bijdra-
ge aan het cardiovasculaire onderzoeksveld.
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